JPWO2019098352A1 - Cosmetological composition, screening method and cosmetological method - Google Patents
Cosmetological composition, screening method and cosmetological method Download PDFInfo
- Publication number
- JPWO2019098352A1 JPWO2019098352A1 JP2019554433A JP2019554433A JPWO2019098352A1 JP WO2019098352 A1 JPWO2019098352 A1 JP WO2019098352A1 JP 2019554433 A JP2019554433 A JP 2019554433A JP 2019554433 A JP2019554433 A JP 2019554433A JP WO2019098352 A1 JPWO2019098352 A1 JP WO2019098352A1
- Authority
- JP
- Japan
- Prior art keywords
- extract
- acid
- cosmetological
- agent
- ipl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 93
- 238000000034 method Methods 0.000 title claims abstract description 32
- 238000012216 screening Methods 0.000 title claims description 16
- 239000000284 extract Substances 0.000 claims abstract description 230
- 230000003796 beauty Effects 0.000 claims abstract description 38
- 239000000419 plant extract Substances 0.000 claims abstract description 31
- 241001474374 Blennius Species 0.000 claims abstract description 26
- 230000002087 whitening effect Effects 0.000 claims abstract description 14
- 229930003935 flavonoid Natural products 0.000 claims abstract description 10
- 150000002215 flavonoids Chemical class 0.000 claims abstract description 10
- 235000017173 flavonoids Nutrition 0.000 claims abstract description 10
- 210000003491 skin Anatomy 0.000 claims description 62
- 239000003795 chemical substances by application Substances 0.000 claims description 47
- 230000014509 gene expression Effects 0.000 claims description 37
- 235000013399 edible fruits Nutrition 0.000 claims description 30
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims description 25
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 239000004480 active ingredient Substances 0.000 claims description 18
- 244000019459 Cynara cardunculus Species 0.000 claims description 16
- 235000019106 Cynara scolymus Nutrition 0.000 claims description 16
- 235000016520 artichoke thistle Nutrition 0.000 claims description 16
- 240000006509 Gynostemma pentaphyllum Species 0.000 claims description 15
- 238000012360 testing method Methods 0.000 claims description 15
- 235000020748 rosemary extract Nutrition 0.000 claims description 14
- 239000000126 substance Substances 0.000 claims description 14
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 claims description 13
- 235000002953 Saxifraga stolonifera Nutrition 0.000 claims description 13
- 244000288377 Saxifraga stolonifera Species 0.000 claims description 13
- 229940092258 rosemary extract Drugs 0.000 claims description 12
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 claims description 12
- 210000004927 skin cell Anatomy 0.000 claims description 12
- 241001672694 Citrus reticulata Species 0.000 claims description 11
- 241000158723 Melia Species 0.000 claims description 10
- 102100037258 Membrane-associated transporter protein Human genes 0.000 claims description 10
- 108091007563 SLC45A2 Proteins 0.000 claims description 10
- 235000019512 sardine Nutrition 0.000 claims description 10
- 101800001649 Heparin-binding EGF-like growth factor Proteins 0.000 claims description 9
- 241001125048 Sardina Species 0.000 claims description 9
- 240000005528 Arctium lappa Species 0.000 claims description 8
- 241000208838 Asteraceae Species 0.000 claims description 8
- 241000196324 Embryophyta Species 0.000 claims description 8
- 241000199919 Phaeophyceae Species 0.000 claims description 8
- 235000004789 Rosa xanthina Nutrition 0.000 claims description 7
- 241000220222 Rosaceae Species 0.000 claims description 7
- 230000001678 irradiating effect Effects 0.000 claims description 7
- 241000192700 Cyanobacteria Species 0.000 claims description 6
- 235000015266 Plantago major Nutrition 0.000 claims description 6
- 241000220151 Saxifragaceae Species 0.000 claims description 6
- 230000007306 turnover Effects 0.000 claims description 6
- 241000195628 Chlorophyta Species 0.000 claims description 5
- 241000206572 Rhodophyta Species 0.000 claims description 5
- 241000208421 Ericaceae Species 0.000 claims description 4
- 235000003805 Musa ABB Group Nutrition 0.000 claims description 4
- 241000013557 Plantaginaceae Species 0.000 claims description 4
- 241000208422 Rhododendron Species 0.000 claims description 4
- 241001093501 Rutaceae Species 0.000 claims description 4
- 241001621828 Monimia Species 0.000 claims description 3
- 102000018710 Heparin-binding EGF-like Growth Factor Human genes 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 43
- 230000003712 anti-aging effect Effects 0.000 abstract description 6
- 238000001126 phototherapy Methods 0.000 abstract description 5
- -1 RAB27A2 Proteins 0.000 description 63
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 32
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 22
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 21
- 108090000765 processed proteins & peptides Proteins 0.000 description 20
- 235000011187 glycerol Nutrition 0.000 description 18
- 239000004615 ingredient Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 16
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 14
- 239000008213 purified water Substances 0.000 description 14
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 14
- 235000014113 dietary fatty acids Nutrition 0.000 description 13
- 239000000194 fatty acid Substances 0.000 description 13
- 229930195729 fatty acid Natural products 0.000 description 13
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 13
- 239000000843 powder Substances 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 239000011734 sodium Substances 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 11
- 235000019437 butane-1,3-diol Nutrition 0.000 description 11
- 229940058015 1,3-butylene glycol Drugs 0.000 description 10
- 239000006071 cream Substances 0.000 description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 10
- 239000006210 lotion Substances 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 10
- 238000011282 treatment Methods 0.000 description 10
- 229940088594 vitamin Drugs 0.000 description 10
- 229930003231 vitamin Natural products 0.000 description 10
- 235000013343 vitamin Nutrition 0.000 description 10
- 239000011782 vitamin Substances 0.000 description 10
- 101001131829 Homo sapiens P protein Proteins 0.000 description 9
- 102100034574 P protein Human genes 0.000 description 9
- 229920002385 Sodium hyaluronate Polymers 0.000 description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 229920001577 copolymer Polymers 0.000 description 9
- 235000013305 food Nutrition 0.000 description 9
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 9
- 229940010747 sodium hyaluronate Drugs 0.000 description 9
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 8
- 229940024606 amino acid Drugs 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 229960005070 ascorbic acid Drugs 0.000 description 8
- 238000009472 formulation Methods 0.000 description 8
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 108010035532 Collagen Proteins 0.000 description 7
- 102000008186 Collagen Human genes 0.000 description 7
- 235000010469 Glycine max Nutrition 0.000 description 7
- 244000068988 Glycine max Species 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 7
- 206010039897 Sedation Diseases 0.000 description 7
- 230000032683 aging Effects 0.000 description 7
- 235000010323 ascorbic acid Nutrition 0.000 description 7
- 239000011668 ascorbic acid Substances 0.000 description 7
- 229920001436 collagen Polymers 0.000 description 7
- 238000007796 conventional method Methods 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 229960004889 salicylic acid Drugs 0.000 description 7
- 229910052708 sodium Inorganic materials 0.000 description 7
- 229940083542 sodium Drugs 0.000 description 7
- 229920001285 xanthan gum Polymers 0.000 description 7
- 235000010493 xanthan gum Nutrition 0.000 description 7
- 239000000230 xanthan gum Substances 0.000 description 7
- 229940082509 xanthan gum Drugs 0.000 description 7
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 6
- 102400001369 Heparin-binding EGF-like growth factor Human genes 0.000 description 6
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 239000002585 base Substances 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 150000007524 organic acids Chemical class 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000002562 thickening agent Substances 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 5
- 108010076876 Keratins Proteins 0.000 description 5
- 102000011782 Keratins Human genes 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 239000002537 cosmetic Substances 0.000 description 5
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 5
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 5
- 235000014655 lactic acid Nutrition 0.000 description 5
- 239000004310 lactic acid Substances 0.000 description 5
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 5
- 229920001296 polysiloxane Polymers 0.000 description 5
- 239000011732 tocopherol Substances 0.000 description 5
- 229930003799 tocopherol Natural products 0.000 description 5
- 229960000401 tranexamic acid Drugs 0.000 description 5
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 5
- 241000512259 Ascophyllum nodosum Species 0.000 description 4
- 241000207199 Citrus Species 0.000 description 4
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 4
- 239000004386 Erythritol Substances 0.000 description 4
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 4
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 4
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 4
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 108010073771 Soybean Proteins Proteins 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 235000020971 citrus fruits Nutrition 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 4
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 210000001339 epidermal cell Anatomy 0.000 description 4
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 4
- 229940009714 erythritol Drugs 0.000 description 4
- 235000019414 erythritol Nutrition 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 4
- 229940093915 gynecological organic acid Drugs 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 210000002752 melanocyte Anatomy 0.000 description 4
- 229960003966 nicotinamide Drugs 0.000 description 4
- 235000005152 nicotinamide Nutrition 0.000 description 4
- 239000011570 nicotinamide Substances 0.000 description 4
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 4
- 235000005985 organic acids Nutrition 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- 210000002826 placenta Anatomy 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 235000010384 tocopherol Nutrition 0.000 description 4
- 229960001295 tocopherol Drugs 0.000 description 4
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 239000004475 Arginine Substances 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 238000000018 DNA microarray Methods 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 3
- 239000005715 Fructose Substances 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- 241000207923 Lamiaceae Species 0.000 description 3
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 235000019482 Palm oil Nutrition 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000009827 Prunus armeniaca Nutrition 0.000 description 3
- 244000018633 Prunus armeniaca Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 229940023476 agar Drugs 0.000 description 3
- 235000010419 agar Nutrition 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 239000002280 amphoteric surfactant Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 235000009697 arginine Nutrition 0.000 description 3
- 235000003704 aspartic acid Nutrition 0.000 description 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 235000010418 carrageenan Nutrition 0.000 description 3
- 229920001525 carrageenan Polymers 0.000 description 3
- 239000000679 carrageenan Substances 0.000 description 3
- 229940113118 carrageenan Drugs 0.000 description 3
- 239000004359 castor oil Substances 0.000 description 3
- 235000019438 castor oil Nutrition 0.000 description 3
- 229940099417 ceramide 2 Drugs 0.000 description 3
- 235000015165 citric acid Nutrition 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- XXJWXESWEXIICW-UHFFFAOYSA-N diethylene glycol monoethyl ether Chemical compound CCOCCOCCO XXJWXESWEXIICW-UHFFFAOYSA-N 0.000 description 3
- 229940075557 diethylene glycol monoethyl ether Drugs 0.000 description 3
- 229940105990 diglycerin Drugs 0.000 description 3
- 235000010350 erythorbic acid Nutrition 0.000 description 3
- 239000004318 erythorbic acid Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 235000013373 food additive Nutrition 0.000 description 3
- 239000002778 food additive Substances 0.000 description 3
- 235000003599 food sweetener Nutrition 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 3
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- 229940026239 isoascorbic acid Drugs 0.000 description 3
- 229940069445 licorice extract Drugs 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- 210000002780 melanosome Anatomy 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000002540 palm oil Substances 0.000 description 3
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 3
- 229960005323 phenoxyethanol Drugs 0.000 description 3
- 239000003504 photosensitizing agent Substances 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 3
- 229940068968 polysorbate 80 Drugs 0.000 description 3
- 229920000053 polysorbate 80 Polymers 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 230000002797 proteolythic effect Effects 0.000 description 3
- 108010033990 rab27 GTP-Binding Proteins Proteins 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 3
- 235000012239 silicon dioxide Nutrition 0.000 description 3
- 239000000600 sorbitol Substances 0.000 description 3
- 235000010356 sorbitol Nutrition 0.000 description 3
- 239000003765 sweetening agent Substances 0.000 description 3
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 3
- 229910052721 tungsten Inorganic materials 0.000 description 3
- 239000011787 zinc oxide Substances 0.000 description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 2
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- DJXPNUIRGNRCPQ-UHFFFAOYSA-N 2-[2,3-bis[2-(16-methylheptadecanoyloxy)ethoxy]propoxy]ethyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCOCC(COCCOC(=O)CCCCCCCCCCCCCCC(C)C)OCCOC(=O)CCCCCCCCCCCCCCC(C)C DJXPNUIRGNRCPQ-UHFFFAOYSA-N 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- 241000544270 Angelica acutiloba Species 0.000 description 2
- 235000016425 Arthrospira platensis Nutrition 0.000 description 2
- 240000002900 Arthrospira platensis Species 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 2
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 2
- 240000003538 Chamaemelum nobile Species 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical class [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- 241000206650 Gelidiaceae Species 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 108010024636 Glutathione Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229920002907 Guar gum Polymers 0.000 description 2
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 240000007049 Juglans regia Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 241001072282 Limnanthes Species 0.000 description 2
- 229920000161 Locust bean gum Polymers 0.000 description 2
- 208000003351 Melanosis Diseases 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 2
- 244000010922 Plantago major Species 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 239000004373 Pullulan Substances 0.000 description 2
- 229920001218 Pullulan Polymers 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- RAHZWNYVWXNFOC-UHFFFAOYSA-N Sulphur dioxide Chemical compound O=S=O RAHZWNYVWXNFOC-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- 241001261506 Undaria pinnatifida Species 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 235000010233 benzoic acid Nutrition 0.000 description 2
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 239000004204 candelilla wax Substances 0.000 description 2
- 235000013868 candelilla wax Nutrition 0.000 description 2
- 229940073532 candelilla wax Drugs 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229940044176 ceramide 3 Drugs 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 229940090934 diphenylsiloxy phenyl trimethicone Drugs 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 229960000735 docosanol Drugs 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 2
- 235000008524 evening primrose extract Nutrition 0.000 description 2
- 239000010475 evening primrose oil Substances 0.000 description 2
- 229940089020 evening primrose oil Drugs 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229940068517 fruit extracts Drugs 0.000 description 2
- 239000001530 fumaric acid Substances 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 239000000174 gluconic acid Substances 0.000 description 2
- 235000012208 gluconic acid Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 229960003180 glutathione Drugs 0.000 description 2
- 235000003969 glutathione Nutrition 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 239000001649 glycyrrhiza glabra l. absolute Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000010417 guar gum Nutrition 0.000 description 2
- 239000000665 guar gum Substances 0.000 description 2
- 229960002154 guar gum Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 2
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 229920001461 hydrolysable tannin Polymers 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 150000002484 inorganic compounds Chemical class 0.000 description 2
- 229910010272 inorganic material Inorganic materials 0.000 description 2
- 238000013532 laser treatment Methods 0.000 description 2
- 229940051810 licorice root extract Drugs 0.000 description 2
- 235000020725 licorice root extract Nutrition 0.000 description 2
- 235000010420 locust bean gum Nutrition 0.000 description 2
- 239000000711 locust bean gum Substances 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- 150000002948 pantothenic acids Chemical class 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 239000000467 phytic acid Substances 0.000 description 2
- 235000002949 phytic acid Nutrition 0.000 description 2
- 229940068041 phytic acid Drugs 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 235000019423 pullulan Nutrition 0.000 description 2
- 102000006581 rab27 GTP-Binding Proteins Human genes 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- 238000010839 reverse transcription Methods 0.000 description 2
- 238000005201 scrubbing Methods 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 229940037001 sodium edetate Drugs 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 235000010199 sorbic acid Nutrition 0.000 description 2
- 239000004334 sorbic acid Substances 0.000 description 2
- 229940075582 sorbic acid Drugs 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 229960002920 sorbitol Drugs 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 229940082787 spirulina Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 229940012831 stearyl alcohol Drugs 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 229940074410 trehalose Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- JYVXNLLUYHCIIH-UHFFFAOYSA-N (+/-)-mevalonolactone Natural products CC1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- CSTRPYAGFNTOEQ-MGMRMFRLSA-N (2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one;octadecanoic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O.CCCCCCCCCCCCCCCCCC(O)=O CSTRPYAGFNTOEQ-MGMRMFRLSA-N 0.000 description 1
- MFYAQFYIDXXKQG-MLCQCVOFSA-N (2s)-2-[[(2s)-4-amino-2-[[(2s)-2-[[(2s)-2-(hexadecanoylamino)-3-hydroxypropanoyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoyl]amino]propanoic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O MFYAQFYIDXXKQG-MLCQCVOFSA-N 0.000 description 1
- KAKVFSYQVNHFBS-UHFFFAOYSA-N (5-hydroxycyclopenten-1-yl)-phenylmethanone Chemical compound OC1CCC=C1C(=O)C1=CC=CC=C1 KAKVFSYQVNHFBS-UHFFFAOYSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 1
- HVNMCCPQUIEPCT-UHFFFAOYSA-N 2-(dimethylazaniumyl)pentanoate Chemical compound CCCC(N(C)C)C(O)=O HVNMCCPQUIEPCT-UHFFFAOYSA-N 0.000 description 1
- FKOKUHFZNIUSLW-UHFFFAOYSA-N 2-Hydroxypropyl stearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(C)O FKOKUHFZNIUSLW-UHFFFAOYSA-N 0.000 description 1
- NCIAZCLIFWUDPR-UHFFFAOYSA-N 2-butyl-3,4,5,6-tetramethylphenol Chemical compound CCCCC1=C(C)C(C)=C(C)C(C)=C1O NCIAZCLIFWUDPR-UHFFFAOYSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 1
- CLAHOZSYMRNIPY-UHFFFAOYSA-N 2-hydroxyethylurea Chemical compound NC(=O)NCCO CLAHOZSYMRNIPY-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- ZSNLEVJATWJBLU-UHFFFAOYSA-N 2-tert-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(C(C)(C)C)(OC)C(=O)C1=CC=CC=C1 ZSNLEVJATWJBLU-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- ZGSCRDSBTNQPMS-UJURSFKZSA-N 3-O-Ethylascorbic acid Chemical compound CCOC1=C(O)C(=O)O[C@@H]1[C@@H](O)CO ZGSCRDSBTNQPMS-UJURSFKZSA-N 0.000 description 1
- DDGPBVIAYDDWDH-UHFFFAOYSA-N 3-[dodecyl(dimethyl)azaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC(O)CS([O-])(=O)=O DDGPBVIAYDDWDH-UHFFFAOYSA-N 0.000 description 1
- RIAJTMUAPNIDSS-UHFFFAOYSA-N 3-aminopropan-1-ol;hydron;chloride Chemical compound Cl.NCCCO RIAJTMUAPNIDSS-UHFFFAOYSA-N 0.000 description 1
- HYCSHFLKPSMPGO-UHFFFAOYSA-N 3-hydroxypropyl dihydrogen phosphate Chemical compound OCCCOP(O)(O)=O HYCSHFLKPSMPGO-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- 229940120145 3-o-ethylascorbic acid Drugs 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000086254 Arnica montana Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- DKLGGNTZHFDTAY-UHFFFAOYSA-N C(CC)(=O)O.C(CCCCCCC)C(C1=CC=CC=C1)=C1N(C(C(N1OC)=O)=O)OC Chemical compound C(CC)(=O)O.C(CCCCCCC)C(C1=CC=CC=C1)=C1N(C(C(N1OC)=O)=O)OC DKLGGNTZHFDTAY-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- BYUQATUKPXLFLZ-UIOOFZCWSA-N CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 Chemical compound CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CN=CN1 BYUQATUKPXLFLZ-UIOOFZCWSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000005635 Caprylic acid (CAS 124-07-2) Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 244000132059 Carica parviflora Species 0.000 description 1
- VQAWRQZAAIQXHM-UHFFFAOYSA-N Cepharanthine Natural products O1C(C=C2)=CC=C2CC(C=23)N(C)CCC3=CC=3OCOC=3C=2OC(=CC=23)C(OC)=CC=2CCN(C)C3CC2=CC=C(O)C1=C2 VQAWRQZAAIQXHM-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 235000008440 Crataegus cuneata Nutrition 0.000 description 1
- 244000160089 Crataegus cuneata Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- SHWNNYZBHZIQQV-UHFFFAOYSA-J EDTA monocalcium diisodium salt Chemical compound [Na+].[Na+].[Ca+2].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O SHWNNYZBHZIQQV-UHFFFAOYSA-J 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 235000011201 Ginkgo Nutrition 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 241000168525 Haematococcus Species 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical class OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 235000000072 L-ascorbyl-6-palmitate Nutrition 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- SSISHJJTAXXQAX-ZETCQYMHSA-N L-ergothioneine Chemical compound C[N+](C)(C)[C@H](C([O-])=O)CC1=CNC(=S)N1 SSISHJJTAXXQAX-ZETCQYMHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 240000000599 Lentinula edodes Species 0.000 description 1
- 235000001715 Lentinula edodes Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- PSFABYLDRXJYID-VKHMYHEASA-N N-Methylserine Chemical compound CN[C@@H](CO)C(O)=O PSFABYLDRXJYID-VKHMYHEASA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 108010075308 N-palmitoyl-seryl-seryl-asparaginyl-alanine Proteins 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 101150068614 OCA2 gene Proteins 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical compound CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- RVSTWRHIGKXTLG-WCXIOVBPSA-N Pangamic acid Chemical compound CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RVSTWRHIGKXTLG-WCXIOVBPSA-N 0.000 description 1
- RVSTWRHIGKXTLG-UHFFFAOYSA-N Pangamic acid Natural products CC(C)N(C(C)C)C(N(C(C)C)C(C)C)C(=O)OCC(O)C(O)C(O)C(O)C(O)=O RVSTWRHIGKXTLG-UHFFFAOYSA-N 0.000 description 1
- 235000011925 Passiflora alata Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 240000008440 Passiflora incarnata Species 0.000 description 1
- 235000011922 Passiflora incarnata Nutrition 0.000 description 1
- 235000013750 Passiflora mixta Nutrition 0.000 description 1
- 235000013731 Passiflora van volxemii Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 235000016976 Quercus macrolepis Nutrition 0.000 description 1
- JYVXNLLUYHCIIH-ZCFIWIBFSA-N R-mevalonolactone, (-)- Chemical compound C[C@@]1(O)CCOC(=O)C1 JYVXNLLUYHCIIH-ZCFIWIBFSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 101150049099 SLC45A2 gene Proteins 0.000 description 1
- 206010039580 Scar Diseases 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 235000005865 Symphytum officinale Nutrition 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 206010043189 Telangiectasia Diseases 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- SHGAZHPCJJPHSC-NWVFGJFESA-N Tretinoin Chemical compound OC(=O)/C=C(\C)/C=C/C=C(C)C=CC1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-NWVFGJFESA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 239000004110 Zinc silicate Substances 0.000 description 1
- FGUZFFWTBWJBIL-XWVZOOPGSA-N [(1r)-1-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)O[C@H](CO)[C@H]1OC[C@H](O)[C@H]1O FGUZFFWTBWJBIL-XWVZOOPGSA-N 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- OEWBEINAQKIQLZ-CMRBMDBWSA-N [(2s)-2-[(2r)-3,4-bis(2-hexyldecanoyloxy)-5-oxo-2h-furan-2-yl]-2-(2-hexyldecanoyloxy)ethyl] 2-hexyldecanoate Chemical compound CCCCCCCCC(CCCCCC)C(=O)OC[C@H](OC(=O)C(CCCCCC)CCCCCCCC)[C@H]1OC(=O)C(OC(=O)C(CCCCCC)CCCCCCCC)=C1OC(=O)C(CCCCCC)CCCCCCCC OEWBEINAQKIQLZ-CMRBMDBWSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- MIUIRGGKIICMBP-NFOZDHADSA-N [27-oxo-27-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]heptacosyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC MIUIRGGKIICMBP-NFOZDHADSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- GNKTZDSRQHMHLZ-UHFFFAOYSA-N [Si].[Si].[Si].[Ti].[Ti].[Ti].[Ti].[Ti] Chemical compound [Si].[Si].[Si].[Ti].[Ti].[Ti].[Ti].[Ti] GNKTZDSRQHMHLZ-UHFFFAOYSA-N 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- QVFOGJXHRGAFSH-UHFFFAOYSA-N acetic acid;1-dodecoxydodecane Chemical compound CC(O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC QVFOGJXHRGAFSH-UHFFFAOYSA-N 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229940063656 aluminum chloride Drugs 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 108010045569 atelocollagen Proteins 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- XVAMCHGMPYWHNL-UHFFFAOYSA-N bemotrizinol Chemical compound OC1=CC(OCC(CC)CCCC)=CC=C1C1=NC(C=2C=CC(OC)=CC=2)=NC(C=2C(=CC(OCC(CC)CCCC)=CC=2)O)=N1 XVAMCHGMPYWHNL-UHFFFAOYSA-N 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- 235000012216 bentonite Nutrition 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 239000010624 camphor oil Substances 0.000 description 1
- 229960000411 camphor oil Drugs 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003064 carboxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- YVPXVXANRNDGTA-WDYNHAJCSA-N cepharanthine Chemical compound C1C(C=C2)=CC=C2OC(=C2)C(OC)=CC=C2C[C@H](C2=C3)N(C)CCC2=CC(OC)=C3OC2=C(OCO3)C3=CC3=C2[C@H]1N(C)CC3 YVPXVXANRNDGTA-WDYNHAJCSA-N 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940048864 ceramide 1 Drugs 0.000 description 1
- 229940095137 ceramide 6 ii Drugs 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- JIHMVMRETUQLFD-UHFFFAOYSA-N cerium(3+);dioxido(oxo)silane Chemical compound [Ce+3].[Ce+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O JIHMVMRETUQLFD-UHFFFAOYSA-N 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229940071124 cocoyl glutamate Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229940039585 comfrey leaf extract Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 108010006161 conchiolin Proteins 0.000 description 1
- 229920002770 condensed tannin Polymers 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 229960003624 creatine Drugs 0.000 description 1
- 239000006046 creatine Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229960002433 cysteine Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- INSRQEMEVAMETL-UHFFFAOYSA-N decane-1,1-diol Chemical compound CCCCCCCCCC(O)O INSRQEMEVAMETL-UHFFFAOYSA-N 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 1
- 229940043276 diisopropanolamine Drugs 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- YVIGPQSYEAOLAD-UHFFFAOYSA-L disodium;dodecyl phosphate Chemical compound [Na+].[Na+].CCCCCCCCCCCCOP([O-])([O-])=O YVIGPQSYEAOLAD-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- ILRSCQWREDREME-UHFFFAOYSA-N dodecanamide Chemical compound CCCCCCCCCCCC(N)=O ILRSCQWREDREME-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- UVCJGUGAGLDPAA-UHFFFAOYSA-N ensulizole Chemical compound N1C2=CC(S(=O)(=O)O)=CC=C2N=C1C1=CC=CC=C1 UVCJGUGAGLDPAA-UHFFFAOYSA-N 0.000 description 1
- 229960000655 ensulizole Drugs 0.000 description 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 description 1
- 229940093497 ergothioneine Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 229950006191 gluconic acid Drugs 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000002628 heparin derivative Substances 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- OGEMCJNRDGZFQF-UHFFFAOYSA-N hexyl 2-benzoyl-4-(diethylamino)-3-hydroxybenzoate Chemical compound CCCCCCOC(=O)C1=CC=C(N(CC)CC)C(O)=C1C(=O)C1=CC=CC=C1 OGEMCJNRDGZFQF-UHFFFAOYSA-N 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 229940079826 hydrogen sulfite Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229940031575 hydroxyethyl urea Drugs 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 description 1
- 229960001669 kinetin Drugs 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940091554 lauryl peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000004137 magnesium phosphate Substances 0.000 description 1
- 229960002261 magnesium phosphate Drugs 0.000 description 1
- 229910000157 magnesium phosphate Inorganic materials 0.000 description 1
- 235000010994 magnesium phosphates Nutrition 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960004452 methionine Drugs 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 1
- 229940057061 mevalonolactone Drugs 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N n-hexadecanoic acid Natural products CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- RGUVUPQQFXCJFC-UHFFFAOYSA-N n-hydroxyoctanamide Chemical compound CCCCCCCC(=O)NO RGUVUPQQFXCJFC-UHFFFAOYSA-N 0.000 description 1
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 1
- 229960002446 octanoic acid Drugs 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940093441 palmitoyl oligopeptide Drugs 0.000 description 1
- 229940055705 pangamic acid Drugs 0.000 description 1
- 108700024047 pangamic acid Proteins 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000011049 pearl Substances 0.000 description 1
- 229940088608 peg-9 polydimethylsiloxyethyl dimethicone Drugs 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229940100498 polysilicone-15 Drugs 0.000 description 1
- 229920002282 polysilicones-15 Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229950008882 polysorbate Drugs 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 229940113124 polysorbate 60 Drugs 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229940114930 potassium stearate Drugs 0.000 description 1
- YRJKYHIIYRGTCC-UHFFFAOYSA-M potassium;2-hydroxy-4-methoxybenzoate Chemical compound [K+].COC1=CC=C(C([O-])=O)C(O)=C1 YRJKYHIIYRGTCC-UHFFFAOYSA-M 0.000 description 1
- MQOCIYICOGDBSG-UHFFFAOYSA-M potassium;hexadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCC([O-])=O MQOCIYICOGDBSG-UHFFFAOYSA-M 0.000 description 1
- ANBFRLKBEIFNQU-UHFFFAOYSA-M potassium;octadecanoate Chemical compound [K+].CCCCCCCCCCCCCCCCCC([O-])=O ANBFRLKBEIFNQU-UHFFFAOYSA-M 0.000 description 1
- PYJBVGYZXWPIKK-UHFFFAOYSA-M potassium;tetradecanoate Chemical compound [K+].CCCCCCCCCCCCCC([O-])=O PYJBVGYZXWPIKK-UHFFFAOYSA-M 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940093625 propylene glycol monostearate Drugs 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 229940084038 salix alba bark extract Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- 229940074404 sodium succinate Drugs 0.000 description 1
- ZDQYSKICYIVCPN-UHFFFAOYSA-L sodium succinate (anhydrous) Chemical compound [Na+].[Na+].[O-]C(=O)CCC([O-])=O ZDQYSKICYIVCPN-UHFFFAOYSA-L 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- HWCHICTXVOMIIF-UHFFFAOYSA-M sodium;3-(dodecylamino)propanoate Chemical compound [Na+].CCCCCCCCCCCCNCCC([O-])=O HWCHICTXVOMIIF-UHFFFAOYSA-M 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940057429 sorbitan isostearate Drugs 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 150000003410 sphingosines Chemical class 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 208000009056 telangiectasis Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 229960001727 tretinoin Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000008513 turmeric extract Substances 0.000 description 1
- 229940052016 turmeric extract Drugs 0.000 description 1
- 235000020240 turmeric extract Nutrition 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- XSMMCTCMFDWXIX-UHFFFAOYSA-N zinc silicate Chemical compound [Zn+2].[O-][Si]([O-])=O XSMMCTCMFDWXIX-UHFFFAOYSA-N 0.000 description 1
- 235000019352 zinc silicate Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Birds (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Botany (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Cosmetics (AREA)
- Dermatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本発明は、肌の美白、アンチエージング等に関してIPL照射に匹敵するだけの皮膚状態の向上効果を十分に奏し、かつ多くの利用者に手軽に使用してもらえる、新しい発想の美容組成物、それを用いた新しい美容方法を提供することを課題とする。本発明は、IPL照射様作用剤を含有する美容組成物である。また、本発明の美容組成物は光施術に匹敵する効果を奏するものであり、IPL照射の代替用として使用できる。さらに、本発明の美容組成物は、上記IPL照射様作用剤が、フラボノイドを含有する植物抽出物、又は海藻抽出物を少なくとも含むことが好ましい。The present invention is a cosmetological composition having a new concept, which sufficiently exerts an effect of improving skin condition comparable to IPL irradiation in terms of skin whitening, anti-aging, etc., and can be easily used by many users. The subject is to provide a new beauty method using. The present invention is a cosmetological composition containing an IPL irradiation-like agent. In addition, the cosmetological composition of the present invention has an effect comparable to that of phototherapy, and can be used as a substitute for IPL irradiation. Further, in the cosmetological composition of the present invention, it is preferable that the IPL irradiation-like agent contains at least a plant extract containing flavonoids or a seaweed extract.
Description
本発明は、美容組成物、スクリーニング方法、美容方法及びIPL照射様作用剤に関する。 The present invention relates to cosmetological compositions, screening methods, cosmetological methods and IPL irradiation-like agents.
近年美容医療の分野において、光施術の人気が高まっている。中でも機器名「フォトフェイシャル(登録商標)」「LimeLight」「Lumenis One」等で知られるIPL(Intense Pulse Light)という、レーザー等とは異なる特殊な波長の光を全顔に照射することで、シミ、そばかす、小じわ、ニキビ跡、赤み等を効果的に改善することができる新しい治療法が注目されている(特許文献1、非特許文献1参照)。IPLとは、紫外線等の皮膚に有害な短波長をカットした幅広い波長域の光をいう。具体的には、可視光線及び赤外線を広く含み、500nm〜1200nmの波長域の複数の波長の光である。このように複数の波長の光を照射することにより、様々な症状を効果的に改善することができる。これらの波長域の光を、用途に応じてフィルターを用いることで波長域及び波形を限定し、皮膚症状に合わせた照射を行うことができる。この治療法は、ハリの低下や毛穴の開き、肌の色ムラ、くすみなどにも効果があり、全顔のエージング症状の改善にも有効であると言われている。上記IPLには複数の波長の光が含まれているため、従来のレーザー治療のようにシミやホクロだけといった局所的な照射ではなく、顔全体に照射していくことで、上記のような複数の問題を効果的に改善することができると考えられている。 In recent years, the popularity of phototherapy has increased in the field of cosmetology. Among them, IPL (Intense Pulse Light), which is known as the device name "Photofacial (registered trademark)", "LimeLight", "Lumenis One", etc., is used to irradiate the entire face with light of a special wavelength different from that of lasers, etc. Attention is being paid to new treatment methods that can effectively improve freckles, fine lines, acne scars, redness, etc. (see Patent Document 1 and Non-Patent Document 1). IPL refers to light in a wide wavelength range that cuts short wavelengths that are harmful to the skin, such as ultraviolet rays. Specifically, it is light having a plurality of wavelengths in the wavelength range of 500 nm to 1200 nm, including a wide range of visible light and infrared rays. By irradiating light of a plurality of wavelengths in this way, various symptoms can be effectively improved. By using a filter depending on the application, light in these wavelength ranges can be irradiated by limiting the wavelength range and waveform and matching the skin symptoms. This treatment method is effective in reducing firmness, opening pores, uneven skin tone, dullness, etc., and is said to be effective in improving the aging symptoms of the entire face. Since the IPL contains light of multiple wavelengths, it is possible to irradiate the entire face instead of local irradiation such as spots and moles as in conventional laser treatment. It is believed that this problem can be effectively remedied.
しかし、上記IPL照射等の光施術を受けることができる医療機関は限られていること、治療する皮膚症状に依っては連続又は継続した施術が推奨されること、また施術に適さない肌状態又は肌特性にある人も存在することから、誰もが手軽に受けられるという訳ではない。しかしながら、肌の美白、アンチエージング等に対する要求は日々高まっているのが現状であり、それらに対し個々のライフスタイルや肌状態又は肌特性等に合わせた選択肢の提案も求められている。また、光施術は、効果は高いものの、その作用メカニズムは不明な点が多かった。 However, the number of medical institutions that can receive the above-mentioned light treatment such as IPL irradiation is limited, continuous or continuous treatment is recommended depending on the skin condition to be treated, and the skin condition is not suitable for the treatment. Not everyone can easily receive it because some people have skin characteristics. However, the current situation is that the demands for skin whitening, anti-aging, etc. are increasing day by day, and there is also a demand for proposals of options according to individual lifestyles, skin conditions, skin characteristics, and the like. In addition, although phototherapy is highly effective, there are many unclear points about its mechanism of action.
本発明は、かかる状況に鑑みてなされたものであり、光施術の作用機序を明らかにし、肌の美白、アンチエージング等に関して、IPL照射と同様に、皮膚状態の向上効果を十分に奏し、かつ多くの利用者に手軽に使用してもらえる、新しい発想の美容組成物、それを用いた新しい美容方法を提供することを課題とする。 The present invention has been made in view of such a situation, clarifies the mechanism of action of phototherapy, and sufficiently exerts the effect of improving the skin condition with respect to skin whitening, anti-aging, etc., as in the case of IPL irradiation. The challenge is to provide a new concept beauty composition that can be easily used by many users, and a new beauty method using the same.
本発明者らは、上記の課題を解決するために鋭意研究した結果、表皮細胞にIPL照射をすることによりメラニン合成及びメラノソーム輸送に関わる遺伝子の発現が抑制されること並びにターンオーバーに関わる遺伝子の発現が促進されることを見出した。すなわち、IPL照射による美白メカニズムは、上記メラニン合成、メラノソーム輸送並びにターンオーバーに関わる遺伝子に働きかけることであると考えられ、この知見を利用することで、化粧品等の外用組成物でIPL照射と同様の効果を実現できる製品、すなわちIPL発想の製品を開発できることに思い至った。この知見に基づいて、IPL照射によって発現が抑制されるこれらの遺伝子の発現を、IPL照射と同様に抑制できる物質を探索したところ、多くの物質のうち、フラボノイドを含有する植物抽出物及び海藻抽出物がIPL照射様の効果を奏することを見出した。本発明の要旨は以下のとおりである。 As a result of diligent research to solve the above problems, the present inventors suppressed the expression of genes involved in melanin synthesis and melanosomes transport by irradiating epidermal cells with IPL, and found that genes involved in turnover. It was found that expression was promoted. That is, it is considered that the whitening mechanism by IPL irradiation acts on the genes involved in the above-mentioned melanin synthesis, melanosomes transport, and turnover, and by utilizing this finding, it is similar to IPL irradiation in external compositions such as cosmetics. I came up with the idea of developing a product that can realize the effect, that is, a product with an IPL concept. Based on this finding, we searched for substances that can suppress the expression of these genes whose expression is suppressed by IPL irradiation in the same way as IPL irradiation. Among many substances, plant extracts and seaweed extracts containing flavonoids were extracted. We have found that the object has an IPL irradiation-like effect. The gist of the present invention is as follows.
[1]IPL照射様作用剤を含有する、美容組成物。
[2]上記IPL照射様作用剤が、有効成分として、フラボノイドを含有する植物抽出物を少なくとも含む、[1]に記載の美容組成物。
[3]上記植物抽出物が、ウリ科、キク科、マメ科、バラ科、ヤナギ科、センダン科、ミカン科、ユキノシタ科、オオバコ科、トケイソウ科、アサ科、モニミア科、トチノキ科、ツツジ科、ボタン科、シソ科、アオイ科、ショウガ科から成る群より選択される少なくとも一種の植物の抽出物である、[2]に記載の美容組成物。
[4]上記IPL照射様作用剤が、有効成分として、海藻抽出物を少なくとも含む、[1]に記載の美容組成物。
[5]上記IPL照射様作用剤が、皮膚細胞におけるメラニン関連分子の発現を調節する、[1]から[4]のいずれかに記載の美容組成物。
[6]上記メラニン関連分子が、OCA2、SLC45A2、及びRAB27A2から成る群より選択される少なくとも一種である、[5]に記載の美容組成物。
[7]前記植物抽出物が、アマチャヅルエキス、アーティチョークエキス、カンゾウ根エキス、ノイバラ果実エキス、セイヨウシロヤナギ樹皮エキス、メリアアザジラクタ葉エキス、マンダリンオレンジ果皮エキス、ユキノシタエキス、セイヨウオオバコ種子エキス、クダモノトケイソウ果実エキス、ホップ花エキス、タンブリッサトリコフィラ葉エキス、ローズマリーエキス、ゴボウエキス、及びアルテアエキスから成る群より選択される少なくとも一種である、[2]、[3]、[5]、[6]のいずれかに記載の美容組成物。
[8]更に、ターンオーバー促進剤(上記IPL照射様作用剤を除く)、抗糖化成分及び美白有効成分からなる群より選択される少なくとも1種を含有する、[1]から[7]のいずれかに記載の美容組成物。
[9]スキントーン向上剤用である、[1]から[8]のいずかに記載の美容組成物。
[10]皮膚細胞にIPL照射することで発現が変化する遺伝子を指標として、スキントーン向上に効果的な成分をスクリーニングすることを特徴とする、スキントーン向上用成分のスクリーニング方法。
[11]皮膚培養細胞に被験物質を作用させる工程、及び上記皮膚培養細胞における上記遺伝子発現を測定する工程を少なくとも含む、[10]に記載のスクリーニング方法。
[12]IPL照射様作用剤を使用することを特徴とする、皮膚状態を改善・向上させるための美容方法。
[13]アマチャヅルエキス、アーティチョークエキス、カンゾウ根エキス、ノイバラ果実エキス、セイヨウシロヤナギ樹皮エキス、メリアアザジラクタ葉エキス、マンダリンオレンジ果皮エキス、ユキノシタエキス、セイヨウオオバコ種子エキス、クダモノトケイソウ果実エキス、ホップ花エキス、タンブリッサトリコフィラ葉エキス、ローズマリーエキス、ゴボウエキス、及びアルテアエキスから成る群より選択される少なくとも一種の植物抽出物を有効成分として含む、IPL照射様作用剤。
[14]褐藻、紅藻、緑藻、藍藻から成る群より選択される少なくとも一種の海藻抽出物を有効成分として含む、IPL照射様作用剤。[1] A cosmetological composition containing an IPL irradiation-like agent.
[2] The cosmetological composition according to [1], wherein the IPL irradiation-like agent contains at least a plant extract containing flavonoids as an active ingredient.
[3] The above plant extracts are: Uridae, Asteraceae, Asteraceae, Rosaceae, Salixaceae, Sendan, Rutaceae, Saxifragaceae, Plantains, Labiatae, Asa, Monimia, Rosaceae, Ericaceae. The beauty composition according to [2], which is an extract of at least one plant selected from the group consisting of Rosaceae, Labiatae, Plantainaceae, and Saxifragaceae.
[4] The cosmetological composition according to [1], wherein the IPL irradiation-like agent contains at least a seaweed extract as an active ingredient.
[5] The cosmetological composition according to any one of [1] to [4], wherein the IPL irradiation-like agent regulates the expression of melanin-related molecules in skin cells.
[6] The cosmetological composition according to [5], wherein the melanin-related molecule is at least one selected from the group consisting of OCA2, SLC45A2, and RAB27A2.
[7] The plant extracts are Amachazuru extract, Artichoke extract, Kanzo root extract, Neubara fruit extract, Seiyoshiroyanagi bark extract, Melia azajirakuta leaf extract, Mandarin orange peel extract, Yukinoshita extract, Seiyouobako seed extract, Kudamonotokeisou. At least one selected from the group consisting of fruit extract, hop flower extract, tambrissa trichophylla leaf extract, rosemary extract, gobo extract, and artea extract, [2], [3], [5], [6]. ] The beauty composition according to any one of.
[8] Further, any of [1] to [7], which contains at least one selected from the group consisting of a turnover accelerator (excluding the above-mentioned IPL irradiation-like agent), an anti-glycation component and a whitening active ingredient. The beauty composition described in Crab.
[9] The cosmetological composition according to any one of [1] to [8], which is for a skin tone improver.
[10] A method for screening a component for improving skin tone, which comprises screening a component effective for improving skin tone using a gene whose expression is changed by irradiating skin cells with IPL as an index.
[11] The screening method according to [10], which comprises at least a step of allowing a test substance to act on cultured skin cells and a step of measuring the gene expression in the cultured skin cells.
[12] A cosmetological method for improving / improving a skin condition, which comprises using an IPL irradiation-like agent.
[13] Amachazuru extract, artichoke extract, kanzo root extract, Neubara fruit extract, Shiroyanagi bark extract, Melia azajirakuta leaf extract, Mandarin orange bark extract, Yukinoshita extract, Oobako seed extract, Kudamonotokeisou fruit extract, Hop flower extract , Tambrissa trichophylla leaf extract, rosemary extract, gobo extract, and an IPL irradiation-like agent containing at least one plant extract selected from the group consisting of Artea extract as an active ingredient.
[14] An IPL irradiation-like agent containing at least one seaweed extract selected from the group consisting of brown algae, red algae, green algae, and blue-green algae as an active ingredient.
本発明によれば、肌の美白、アンチエージング等に関して、IPL照射と同様の皮膚状態の向上効果を十分に奏し、かつ多くの利用者に手軽に使用してもらえる、新しい発想の美容組成物を提供することができる。また、それを用いた新しい美容方法も提供することができる。 According to the present invention, with respect to skin whitening, anti-aging, etc., a cosmetological composition having a new concept, which can sufficiently exert the same skin condition improving effect as IPL irradiation and can be easily used by many users, can be obtained. Can be provided. It is also possible to provide a new beauty method using the same.
以下、本発明について詳細に説明する。なお、本明細書中で使用される用語は、特に言及しない限り、当該技術分野で通常用いられる意味で解釈される。 Hereinafter, the present invention will be described in detail. Unless otherwise specified, the terms used in the present specification are interpreted in the meanings commonly used in the art.
<美容組成物>
本発明の美容組成物は、IPL照射様作用剤を含有する。ここで、IPL照射様作用剤とは、被験体に対してIPLを照射したときと同様の効果を与えることが可能な組成物をいう。これはIPL照射等の光施術の代替となり得る組成物、すなわちIPL照射代替用美容組成物である。なお、IPL照射様作用剤としては、IPLを被験体に照射して得られる効果のうちの一部の効果を与えるものであってもよい。本発明の美容組成物は、単独でも効果を奏するものであるが、IPL照射等の光施術と組み合わせることにより、IPL照射の効果を向上させ、長時間持続させることも可能である。<Cosmetology composition>
The cosmetological composition of the present invention contains an IPL irradiation-like agent. Here, the IPL irradiation-like agent refers to a composition capable of giving the same effect as when the subject is irradiated with IPL. This is a composition that can be an alternative to phototherapy such as IPL irradiation, that is, a cosmetological composition that is an alternative to IPL irradiation. The IPL irradiation-like agent may give a part of the effects obtained by irradiating the subject with the IPL. Although the cosmetological composition of the present invention is effective by itself, it is possible to improve the effect of IPL irradiation and maintain it for a long time by combining it with a light treatment such as IPL irradiation.
IPLを被験体に照射して得られる効果としては、例えば、皮膚細胞におけるメラニン関連分子の発現調節効果、全顔の美白、スキントーンの向上効果が得られる。また、全顔のくすみ、ハリのなさ、毛穴目立ち、肌の色むら、乾燥などのエージング症状の改善効果(スキントーンの改善効果)が挙げられる。上記メラニン関連分子(遺伝子及び/又はタンパク)としては、OCA2、SLC45A2、RAB27A2、HB‐EGF等が挙げられる。IPL照射によって、これらの分子のうち、OCA2、SLC45A2、RAB27A2の発現は抑制する方向に調節される。また、これらの分子のうち、HB−EGFの発現は促進する方向に調節される。すなわち、本発明の美容組成物は、OCA2、SLC45A2及びRAB27A2から成る群より選択される少なくとも一種の遺伝子発現抑制用の美容組成物、又はHB−EGFの遺伝子発現促進用の美容組成物であるとも言える。また、本発明の美容組成物は、上記の遺伝子発現を抑制又は促進することから、IPL照射と同様のスキントーン向上用及び/又はスキントーン改善用の美容組成物であるとも言える。 The effects obtained by irradiating the subject with IPL include, for example, the effect of regulating the expression of melanin-related molecules in skin cells, the effect of whitening the entire face, and the effect of improving skin tone. In addition, the effect of improving aging symptoms such as dullness of the entire face, lack of firmness, conspicuous pores, uneven skin tone, and dryness (skin tone improving effect) can be mentioned. Examples of the melanin-related molecule (gene and / or protein) include OCA2, SLC45A2, RAB27A2, HB-EGF and the like. By IPL irradiation, the expression of OCA2, SLC45A2, and RAB27A2 among these molecules is regulated in a direction of suppressing. In addition, among these molecules, the expression of HB-EGF is regulated in a direction that promotes it. That is, the cosmetological composition of the present invention may be at least one cosmetological composition for suppressing gene expression selected from the group consisting of OCA2, SLC45A2 and RAB27A2, or a cosmetological composition for promoting gene expression of HB-EGF. I can say. Further, since the beauty composition of the present invention suppresses or promotes the above-mentioned gene expression, it can be said that it is a beauty composition for skin tone improvement and / or skin tone improvement similar to IPL irradiation.
本発明の美容組成物は、上記IPL照射様作用剤に加えて、本発明の効果を損なわない範囲で、その他の任意成分を含んでいてもよい。以下に、IPL照射様作用剤及びその他の任意成分について説明する。 The cosmetological composition of the present invention may contain, in addition to the above-mentioned IPL irradiation-like agent, other optional components as long as the effects of the present invention are not impaired. The IPL irradiation-like agent and other optional components will be described below.
[IPL照射様作用剤]
本発明の美容組成物においてIPL照射様作用剤は、被験体にIPL照射をしたときと同様の効果を与えることが可能な物質であれば特に限定されないが、例えば、各種植物抽出物等を有効成分として含有するものが挙げられ、中でもフラボノイドを含有する植物抽出物を少なくとも含むものであることが好ましい。また、海藻抽出物を少なくとも含むものであることも好ましい。[IPL irradiation-like agent]
In the beauty composition of the present invention, the IPL irradiation-like agent is not particularly limited as long as it is a substance capable of giving the same effect as when the subject is irradiated with IPL, but for example, various plant extracts and the like are effective. Examples thereof include those contained as an ingredient, and among them, those containing at least a plant extract containing flavonoids are preferable. It is also preferable that it contains at least a seaweed extract.
フラボノイドを含有する植物抽出物としては、例えば、ウリ科、キク科、マメ科、バラ科、ヤナギ科、センダン科、ミカン科、ユキノシタ科、オオバコ科、トケイソウ科、アサ科、モニミア科、トチノキ科、ツツジ科、ボタン科、シソ科、アオイ科、ショウガ科等の植物の抽出物が挙げられる。 Plant extracts containing flavonoids include, for example, Rosaceae, Asteraceae, Asteraceae, Rosaceae, Salixaceae, Sendan, Rutaceae, Saxifragaceae, Plantains, Ericaceae, Asa, Monimia, Ericaceae. , Asteraceae, Rosaceae, Labiatae, Plantains, Saxifragaceae and other plant extracts.
上記植物抽出物としては、例えば、アマチャヅルエキス、アーティチョークエキス、カンゾウ根エキス、ノイバラ果実エキス、セイヨウシロヤナギ樹皮エキス、メリアアザジラクタ葉エキス、マンダリンオレンジ果皮エキス、ユキノシタエキス、セイヨウオオバコ種子エキス、クダモノトケイソウ果実エキス、ホップ花エキス、タンブリッサトリコフィラ葉エキス、フユボダイジュ花エキス、加水分解ダイズペプチド、セイヨウシロヤナギ樹皮エキス、イザヨイバラエキス、ローズマリーエキス、ゴボウエキス、アルテアエキス等が挙げられる。上記植物の抽出する部位としては、例えば葉、花、実、根、茎、皮、枝、果実、果皮、種子などが挙げられる。抽出に際しては植物原料をそのまま用いてもよく、乾燥させて用いてもよい。植物原料は粉砕して用いることもできる。また、化粧品原料等として市販されている植物エキスを使用してもよい。 Examples of the above-mentioned plant extracts include Amachazuru extract, Artichoke extract, Kanzo root extract, Neubara fruit extract, Shiroyanagi bark extract, Melia azalea leaf extract, Mandarin orange peel extract, Yukinoshita extract, Seiyouobako seed extract, and Kudamonotokeisou. Examples thereof include fruit extract, hop flower extract, tambrissa trichophylla leaf extract, fuyubodaiju flower extract, hydrolyzed soybean peptide, blue-green algae bark extract, isayoibara extract, rosemary extract, gobo extract, and artea extract. Examples of the site to be extracted from the plant include leaves, flowers, fruits, roots, stems, skins, branches, fruits, pericarps, seeds and the like. At the time of extraction, the plant raw material may be used as it is, or it may be dried and used. The plant material can also be crushed and used. Further, a commercially available plant extract may be used as a raw material for cosmetics.
上記海藻抽出物に用いられる海藻としては、例えば、褐藻(ガゴメコンブ、リシリコンブ、ミツイシコンブ、マコンブ、ナガコンブ、ワカメ等)、紅藻(テングサ等)、緑藻(アオノリ等)、藍藻(スピルリナ等)等の海藻類の抽出物が挙げられる。抽出に際しては、海藻原料をそのまま用いてもよく、乾燥させて用いても良い。植物原料は粉砕して用いることもできる。また、化粧品原料等として市販されている海藻エキスを使用しても良い。これら海藻類は1種単独で用いても良いし、2種以上を併用しても良い。これらのうち、メラニン関連分子の発現を促進させる効果に優れるという観点から、褐藻の抽出物が好ましく、コンブ抽出物がより好ましく、ガゴメコンブ抽出物がさらに好ましい。 Seaweeds used in the above seaweed extract include, for example, brown algae (Gagomekonbu, Risilimb, Mitsuishikonbu, Macombu, Nagakombu, Wakame seaweed, etc.), red algae (Gelidiaceae, etc.), green algae (Aonori, etc.), and blue-green algae (Spirulina, etc.). Kind of extract. At the time of extraction, the seaweed raw material may be used as it is, or may be dried and used. The plant material can also be crushed and used. Further, a seaweed extract commercially available as a raw material for cosmetics may be used. These seaweeds may be used alone or in combination of two or more. Of these, the brown algae extract is preferable, the kelp extract is more preferable, and the gagome kelp extract is further preferable, from the viewpoint of being excellent in the effect of promoting the expression of melanin-related molecules.
これらのうち、メラニン関連分子の中で、特にOCA2遺伝子の発現を低下させる効果に優れるという観点から、アーティチョークエキス、クダモノトケイソウ果実エキス、アマチャヅルエキス、加水分解ダイズペプチド(加水分解ダイズタンパク)、カンゾウ根エキス、ノイバラ果実エキス、タンブリッサトリコフィラ葉エキス、フユボダイジュ花エキスが好ましく、アーティチョークエキス、クダモノトケイソウ果実エキス、カンゾウ根エキス、ノイバラ果実エキスがより好ましい。 Among these, among the melanin-related molecules, from the viewpoint of being particularly excellent in the effect of lowering the expression of the OCA2 gene, artichoke extract, kudamonotokeisou fruit extract, amachaduru extract, hydrolyzed soybean peptide (hydrolyzed soybean protein), citrus root Extracts, Neubara fruit extract, Tambrissa trichophylla leaf extract, Fuyubodaiju flower extract are preferable, and Artichoke extract, Kudamonotokeisou fruit extract, Kanzo root extract, and Neubara fruit extract are more preferable.
メラニン関連分子の中で、特にSLC45A2遺伝子の発現を低下させる効果に優れるという観点から、アマチャヅルエキス、カンゾウ根エキス、ノイバラ果実エキス、アーティチョークエキス、加水分解ダイズペプチド、セイヨウシロヤナギ樹皮エキス、メリアアザジラクタ葉エキス、マンダリンオレンジ果皮エキス、ユキノシタエキス、セイヨウオオバコ種子エキス、フユボダイジュ花エキスが好ましく、アマチャヅルエキス、カンゾウ根エキス、ノイバラ果実エキスがより好ましい。 Among the melanin-related molecules, from the viewpoint of being particularly excellent in the effect of lowering the expression of the SLC45A2 gene, Amachazuru extract, Kanzo root extract, Neubara fruit extract, Artichoke extract, Hydrolyzed soybean peptide, Shiroyanagi bark extract, Melia azajirakuta Leaf extract, mandarin orange peel extract, yukinoshita extract, blue-green algae seed extract, and fuyubodaiju flower extract are preferable, and amachazuru extract, kanzo root extract, and neurose fruit extract are more preferable.
メラニン関連分子の中で、特にRAB27A2遺伝子の発現を低下させる効果に優れるという観点から、アマチャヅルエキス、アーティチョークエキス、加水分解ダイズペプチド、カンゾウ根エキス、ノイバラ果実エキス、ユキノシタエキス、セイヨウオオバコ種子エキス、タンブリッサトリコフィラ葉エキス、フユボダイジュ花エキス、イザヨイバラエキスが好ましい。 Among the melanin-related molecules, from the viewpoint of being particularly excellent in the effect of lowering the expression of the RAB27A2 gene, Amachazuru extract, artichoke extract, hydrolyzed soybean peptide, citrus root extract, Neubara fruit extract, Yukinoshita extract, broadleaf plantain seed extract, tan. Brissa trichophylla leaf extract, Fuyubodaiju flower extract, and Izayoi rose extract are preferable.
メラニン関連分子のうち、OCA2、SLC45A2、RAB27A2のいずれか2つ以上の遺伝子発現を低下させる効果に優れるという観点から、アマチャヅルエキス、アーティチョークエキス、加水分解ダイズペプチド、カンゾウ根エキス、ノイバラ果実エキス、ユキノシタエキス、セイヨウオオバコ種子エキス、フユボダイジュ花エキス、セイヨウシロヤナギ樹皮エキス、マンダリンオレンジ果皮エキス、タンブリッサトリコフィラ葉エキスが好ましく、3つの遺伝子全ての発現を低下させる効果に優れるという観点から、アマチャヅルエキス、アーティチョークエキス、加水分解ダイズペプチド、カンゾウ根エキス、ノイバラ果実エキス、ユキノシタエキス、セイヨウオオバコ種子エキス、フユボダイジュ花エキスがより好ましい。 Among the melanin-related molecules, from the viewpoint of excellent effect of reducing the expression of any two or more of OCA2, SLC45A2, and RAB27A2, Amachazuru extract, artichoke extract, hydrolyzed soybean peptide, citrus root extract, Neubara fruit extract, Yukinoshita Extract, sardine seed extract, fuyubodaiju flower extract, sardine bark extract, mandarin orange peel extract, tambrissa trichophylla leaf extract are preferable, and from the viewpoint of excellent effect of lowering the expression of all three genes, amachazuru extract, Artichoke extract, hydrolyzed soybean peptide, citrus root extract, Neubara fruit extract, Yukinoshita extract, Oobako seed extract, and Fuyubodaiju flower extract are more preferable.
メラニン関連分子のうち、HB‐EGF遺伝子の発現を促進させる効果に優れるという観点から、ローズマリーエキス、海藻抽出物、アルテアエキス、クダモノトケイソウ果実エキス、ゴボウエキスが好ましく、海藻抽出物、アルテアエキス、ローズマリーエキスがより好ましい。 Among the melanin-related molecules, rosemary extract, seaweed extract, artea extract, kudamonotokeisou fruit extract, and gobo extract are preferable, and seaweed extract, artea extract, and so on, from the viewpoint of excellent effect of promoting the expression of HB-EGF gene. Rosemary extract is more preferred.
本発明の効果を総合的に鑑みると、本発明の美容組成物における上記植物抽出物としては、アマチャヅルエキス、アーティチョークエキス、カンゾウ根エキス、ノイバラ果実エキス、セイヨウシロヤナギ樹皮エキス、メリアアザジラクタ葉エキス、マンダリンオレンジ果皮エキス、ユキノシタエキス、セイヨウオオバコ種子エキス、クダモノトケイソウ果実エキス、ホップ花エキス、タンブリッサトリコフィラ葉エキス、ローズマリーエキス、アルテアエキスが好ましい。また、本発明の美容組成物における上記海藻抽出物としては褐藻抽出物が好ましく、コンブ抽出物がより好ましく、ガゴメコンブ抽出物がさらに好ましい。 Considering the effects of the present invention comprehensively, the above-mentioned plant extracts in the beauty composition of the present invention include Amachazuru extract, Artichoke extract, Kanzo root extract, Neubara fruit extract, Shiroyanagi bark extract, and Melia azajirakuta leaf extract. , Mandarin orange peel extract, Yukinoshita extract, Strawberry seed extract, Kudamonotokeisou fruit extract, Hop flower extract, Tambrissa trichophylla leaf extract, Rosemary extract, Artea extract are preferable. Further, as the seaweed extract in the beauty composition of the present invention, a brown algae extract is preferable, a kelp extract is more preferable, and a gagome kelp extract is further preferable.
本発明の美容組成物における上記IPL照射様作用剤の含有量としては、上記IPL照射様作用剤が上記植物抽出物である場合、0.0001重量%〜20重量%であり、0.001重量%〜10重量%であることが好ましく、0.01重量%〜5重量%であることがより好ましく、0.05重量%〜3重量%であることがさらに好ましい。なお、本発明の美容組成物は、上記植物抽出物を1種単独で含んでもよいし、2種以上を含んでもよい。本発明の美容組成物が上記植物抽出物を2種以上含む場合、これら2種以上の植物抽出物の含有量の合計を上記植物抽出物の含有量とする。 The content of the IPL irradiation-like agent in the beauty composition of the present invention is 0.0001% by weight to 20% by weight, 0.001% by weight when the IPL irradiation-like agent is the plant extract. % To 10% by weight, more preferably 0.01% by weight to 5% by weight, and even more preferably 0.05% by weight to 3% by weight. The cosmetological composition of the present invention may contain the above plant extract alone or in combination of two or more. When the cosmetological composition of the present invention contains two or more kinds of the above plant extracts, the total content of these two or more kinds of plant extracts is defined as the content of the above plant extracts.
本発明による美容方法、美容組成物は、チロシナーゼ活性阻害等による従来の美白メカニズムとは異なり、肌の白さを決定づけるメラニン合成及びメラノソーム輸送に関わる遺伝子に直接働きかけることで、スキントーンをアップさせる効果(スキントーン向上効果)を奏するものである。 The cosmetological method and cosmetological composition according to the present invention have an effect of improving skin tone by directly acting on genes involved in melanin synthesis and melanosomes transport, which determine skin whiteness, unlike the conventional whitening mechanism by inhibiting tyrosinase activity. (Skin tone improvement effect) is achieved.
ここで、スキントーンのアップとは、シミやソバカス、加齢に伴う肌のくすみや色素沈着を改善し、より自然で均一な肌色に近づけること(スキントーン改善)に加えて、本来よりの肌色のトーンが濃い肌の肌トーンをアップさせることも含まれる。 Here, improving skin tone means improving spots, freckles, dullness and pigmentation of the skin with aging, and making the skin color more natural and uniform (skin tone improvement), as well as the original skin color. It also includes improving the skin tone of dark skin.
本発明の美容組成物が含む任意成分としては、例えば、美白有効成分、ターンオーバー促進剤(本発明のIPL照射様作用剤を除く)、抗糖化成分、抗酸化成分、老化防止成分、抗炎症剤、清涼化剤、殺菌剤、ビタミン類、有機酸、保湿成分、多価アルコール、スクラブ剤、紫外線吸収成分、紫外線散乱成分、収斂成分、ペプチド又はその誘導体、アミノ酸又はその誘導体、洗浄成分、角質柔軟成分、細胞賦活化成分、血行促進作用成分等が挙げられる。なお、本発明の美容組成物において、これらの成分は、それぞれ1種単独で用いてもよいし、2種以上を併用してもよい。 Optional ingredients contained in the cosmetological composition of the present invention include, for example, a whitening active ingredient, a turnover accelerator (excluding the IPL irradiation-like agent of the present invention), an antiglycation ingredient, an antioxidant ingredient, an antiaging ingredient, and an anti-inflammatory ingredient. Agents, refreshing agents, bactericides, vitamins, organic acids, moisturizing ingredients, polyhydric alcohols, scrubbing agents, UV absorbing ingredients, UV scattering ingredients, astringent ingredients, peptides or derivatives thereof, amino acids or derivatives thereof, cleaning ingredients, keratin Examples thereof include a softening component, a cell activating component, and a blood circulation promoting action component. In the cosmetological composition of the present invention, each of these components may be used alone or in combination of two or more.
上記美白有効成分としては、例えば、トコフェロール、ビタミンC及びその誘導体、アルブチン、コウジ酸、プラセンタ、エラグ酸、ニコチン酸アミド、トラネキサム酸及びその誘導体、ハイドロキノン、ルシノール(登録商標)、4−メトキシサリチル酸カリウム塩、リノール酸及びその誘導体、等が挙げられる。 Examples of the whitening active ingredient include tocopherol, vitamin C and its derivatives, arbutin, kojic acid, placenta, ellagic acid, nicotinamide, tranexamic acid and its derivatives, hydroquinone, rucinol (registered trademark), potassium 4-methoxysalicylate. Examples thereof include salts, linoleic acid and derivatives thereof.
上記ターンオーバー促進剤としては、例えば、後述するビタミン類、角質柔軟成分、細胞賦活化成分、血行促進成分等が挙げられる。 Examples of the turnover accelerator include vitamins, keratin softening components, cell activating components, blood circulation promoting components, etc., which will be described later.
上記抗糖化成分としては、例えば、ブドレジャアキシラリス葉エキス等の植物エキス、月見草油、アムラーの果実、果汁又はそれらの抽出物、L−アルギニン、L−リジン、加水分解カゼイン、加水分解性タンニン、カルノシン等が挙げられる。 Examples of the anti-glycation component include plant extracts such as Budreja axilaris leaf extract, evening primrose oil, Amler fruit, fruit juice or extracts thereof, L-arginine, L-lysine, hydrolyzed casein, and hydrolyzable tannin. , Carnosin and the like.
上記抗酸化成分としては、例えば、植物(例えば、ブドウ、オタネニンジン、及びコンフリー等)に由来する成分;プロアントシアニジン、トコフェロール及びその誘導体、アスコルビン酸及びその誘導体、へスペリジン及びその誘導体、エルゴチオネイン、亜硫酸水素ナトリウム、エリソルビン酸及びその塩、フラボノイド、グルタチオン等が挙げられる。 Examples of the antioxidant component include components derived from plants (for example, grapes, glutathione, and comfrey); proanthocyanidins, tocopherols and their derivatives, ascorbic acid and its derivatives, hesperidin and its derivatives, ergothioneine, sulfite. Examples thereof include sodium hydrogen hydrogen, erythorbic acid and salts thereof, flavonoids, glutathione and the like.
上記老化防止成分としては、例えば、加水分解大豆タンパク、レチノイド(レチノール及びその誘導体、レチノイン酸、及びレチナール等)、パンガミン酸、カイネチン、ウルソール酸、ウコンエキス、スフィンゴシン誘導体、ケイ素、ケイ酸、N−メチル−L−セリン、メバロノラクトン等が挙げられる。 Examples of the antiaging component include hydrolyzed soy protein, retinoids (retinol and its derivatives, retinoic acid, retinal, etc.), pangamic acid, kinetin, ursoleic acid, turmeric extract, sphingosine derivatives, silicon, silicic acid, N-. Examples thereof include methyl-L-serine and mevalonolactone.
上記抗炎症剤としては、例えば、アラントイン及びその誘導体、グリチルレチン酸及びその誘導体、グリチルリチン酸及びその誘導体、サリチル酸誘導体、アミノカプロン酸、アズレン及びその誘導体、酸化亜鉛、酢酸トコフェロール等が挙げられる。 Examples of the anti-inflammatory agent include allantoin and its derivatives, glycyrrhetinic acid and its derivatives, glycyrrhizic acid and its derivatives, salicylic acid derivatives, aminocaproic acid, azulene and its derivatives, zinc oxide, tocopherol acetate and the like.
上記清涼化剤としては、例えば、メントール、カンフル、ゲラニオール、等のテルペン類(これらはd体、l体又はdl体のいずれでもよい。);ユーカリ油、ベルガモット油、ペパーミント油、クールミント油、スペアミント油、ハッカ油、等の精油等が挙げられる。 Examples of the refreshing agent include terpenes such as menthol, camphor, geraniol, etc. (these may be d-form, l-form or dl-form); eucalyptus oil, bergamot oil, peppermint oil, cool mint oil, etc. Essential oils such as sparemint oil and camphor oil can be mentioned.
上記殺菌剤としては、例えば、イソプロピルメチルフェノール、サリチル酸、塩化ベンザルコニウム、エタノール、塩化ベンゼトニウム、グルコン酸及びその誘導体、感光素101号、感光素201号、パラベン、フェノキシエタノール、ピロクトオラミン、ミコナゾール等が挙げられる。 Examples of the above-mentioned bactericide include isopropylmethylphenol, salicylic acid, benzalkonium chloride, ethanol, benzethonium chloride, gluconic acid and derivatives thereof, Photosensitizer No. 101, Photosensitizer No. 201, paraben, phenoxyethanol, pyroctoolamine, myconazole and the like. Be done.
上記ビタミン類としては、水溶性ビタミン及び油溶性ビタミンのいずれであってもよく、例えば、ビタミンB6類、パントテン酸類、ニコチン酸類、ビタミンB1類、ビタミンB2類、ビオチン類葉酸類、ビタミンB12類、水溶性のビタミンC類、油溶性のビタミンC類、ビタミンK類;フェルラ酸等のビタミン様作用因子等が挙げられる。 The vitamins may be either water-soluble vitamins or oil-soluble vitamins. For example, vitamin B6s, pantothenic acids, nicotinic acids, vitamins B1, vitamins B2, biotins folic acids, vitamins B12, etc. Water-soluble vitamin Cs, oil-soluble vitamin Cs, vitamin Ks; vitamin-like acting factors such as ferulic acid can be mentioned.
上記有機酸としては、例えば、グルコン酸、アスパラギン酸、アミノエチルスルホン酸、クエン酸、グルタミン酸、コハク酸、シュウ酸、フマル酸、プロピオン酸、リンゴ酸、サリチル酸、グリコール酸、フィチン酸、酒石酸、酢酸、乳酸、及びこれらの塩が挙げられる。塩としては、例えば、硫酸、塩酸又はリン酸等の鉱酸の塩、マレイン酸又はメタンスルホン酸等の有機酸の塩、ナトリウム又はカリウム等のアルカリ金属塩、アルカリ土類金属塩、アンモニウム塩等が挙げられる。 Examples of the organic acids include gluconic acid, aspartic acid, aminoethyl sulfonic acid, citric acid, glutamate, succinic acid, oxalic acid, fumaric acid, propionic acid, malic acid, salicylic acid, glycolic acid, phytic acid, tartaric acid, and acetic acid. , Lactic acid, and salts thereof. Examples of the salt include a salt of a mineral acid such as sulfuric acid, hydrochloric acid or phosphoric acid, a salt of an organic acid such as maleic acid or methanesulfonic acid, an alkali metal salt such as sodium or potassium, an alkaline earth metal salt, an ammonium salt and the like. Can be mentioned.
上記保湿成分としては、例えば、ヒアルロン酸ナトリウム、ヘパリン類似物質、コンドロイチン硫酸ナトリウム、コラーゲン、エラスチン、ケラチン、キチン、キトサン、プロテオグリカン等の高分子化合物;グリシン、アスパラギン酸、アルギニン等のアミノ酸;乳酸ナトリウム、尿素、ピロリドンカルボン酸ナトリウム等の天然保湿因子;セラミド、コレステロール、リン脂質等の脂質;カミツレエキス、ハマメリスエキス、チャエキス、シソエキス等の植物抽出エキス、グリセリンなどの多価アルコール等が挙げられる。 Examples of the moisturizing component include high molecular compounds such as sodium hyaluronate, heparin analog, sodium chondroitin sulfate, collagen, elastin, keratin, chitin, chitosan, and proteoglycan; amino acids such as glycine, aspartic acid, and arginine; sodium lactate, Natural moisturizing factors such as urea and sodium pyrrolidone carboxylate; lipids such as ceramide, cholesterol and phospholipids; plant extracts such as chamomile extract, hamamelis extract, cha extract and perilla extract, and polyhydric alcohols such as glycerin.
上記多価アルコールとしては、炭素数2〜10のものが好ましく、例えば、グリセリン、ジグリセリン、トリグリセリン、プロピレングリコール、ジプロピレングリコール、1,3−ブタンジオール、エチレングリコール、ジエチレングリコール、イソプレングリコール、1、3−ブチレングリコール、ソルビトール、キシリトール、エリスリトール、マンニトール、ペンタンジオール、ヘキサンジオール、オクタンジオール、デカンジオール、ネオペンチルグリコール等が挙げられる。 The polyhydric alcohol preferably has 2 to 10 carbon atoms, and for example, glycerin, diglycerin, triglycerin, propylene glycol, dipropylene glycol, 1,3-butanediol, ethylene glycol, diethylene glycol, isoprene glycol, 1 , 3-butylene glycol, sorbitol, xylitol, erythritol, mannitol, pentandiol, hexanediol, octanediol, decanediol, neopentyl glycol and the like.
上記スクラブ剤としては、例えば、アプリコット核粉末、アーモンド殻粉末、アンズ核粉末、塩化ナトリウム粒、オリーブ核粉末、海水乾燥物粒、キャンデリラワックス、くるみ殻粉末、さくらんぼ核粉末、サンゴ粉末、炭粉末、はしばみ殻粉末、ポリエチレン末、無水ケイ酸等が挙げられる。 Examples of the scrubbing agent include apricot kernel powder, almond shell powder, apricot kernel powder, sodium chloride granules, olive kernel powder, seawater dried product granules, candelilla wax, walnut shell powder, cherry kernel powder, coral powder, and charcoal powder. , Cherries shell powder, polyethylene powder, silicic anhydride and the like.
上記紫外線吸収成分としては、例えば、メトキシケイ皮酸エチルヘキシル、ジエチルアミノヒドロキシベンゾイル安息香酸ヘキシル、ビスエチルヘキシルオキシフェノールメトキシフェニルトリアジン、エチルヘキシルトリアゾン、t−ブチルメトキシジベンゾイルメタン、オクトクリレン、ポリシリコーン−15、メチレンビスベンゾトリアゾリルテトラメチルブチルフェノール、ジメトキシベンジリデンジオキソイミダゾリジンプロピオン酸オクチル、フェニルベンズイミダゾールスルホン酸等が挙げられる。 Examples of the ultraviolet absorbing component include ethylhexyl methoxycinnamate, hexyl diethylaminohydroxybenzoylbenzoate, bisethylhexyloxyphenol methoxyphenyltriazine, ethylhexyltriazone, t-butylmethoxydibenzoylmethane, octocrylene, polysilicone-15, and methylene. Examples thereof include bisbenzotriazolyl tetramethylbutylphenol, octyl dimethoxybenzylidene dioxoimidazolidine propionate, and phenylbenzimidazole sulfonic acid.
上記紫外線散乱成分としては、例えば、含水ケイ酸、ケイ酸亜鉛、ケイ酸セリウム、ケイ酸チタン、酸化ジルコニウム、酸化セリウム、酸化チタン、酸化鉄、酸化亜鉛、無水ケイ酸等の無機化合物、これらの無機化合物を含水ケイ酸、水酸化アルミニウム、マイカやタルク等の無機粉体で被覆したり、ポリアミド、ポリエチレン、ポリエステル、ポリスチレン、ナイロン等の樹脂粉体に複合化したもの、さらにシリコーン油や脂肪酸アルミニウム塩等で処理したもの等が挙げられる。 Examples of the ultraviolet scattering component include inorganic compounds such as hydrous silicic acid, zinc silicate, cerium silicate, titanium silicate, zirconium oxide, cerium oxide, titanium oxide, iron oxide, zinc oxide, and silicic anhydride. Inorganic compounds coated with inorganic powders such as hydrous silicic acid, aluminum hydroxide, mica and talc, composited with resin powders such as polyamide, polyethylene, polyester, polystyrene and nylon, and silicone oil and aluminum fatty acid Examples thereof include those treated with salt or the like.
上記収斂成分としては、例えば、ミョウバン、硫酸亜鉛、塩化アルミニウム、スルホ石炭酸亜鉛、タンニン酸等が挙げられる。 Examples of the astringent component include alum, zinc sulfate, aluminum chloride, zinc sulfonate, tannic acid and the like.
上記ペプチド又はその誘導体としては、例えば、ケラチン分解ペプチド、加水分解ケラチン、コラーゲン、魚由来コラーゲン、アテロコラーゲン、ゼラチン、エラスチン、エラスチン分解ペプチド、コラーゲン分解ペプチド、加水分解コラーゲン、塩化ヒドロキシプロピルアンモニウム加水分解コラーゲン、エラスチン分解ペプチド、コンキオリン分解ペプチド、加水分解コンキオリン、シルク蛋白分解ペプチド、加水分解シルク、ラウロイル加水分解シルクナトリウム、大豆蛋白分解ペプチド、加水分解大豆蛋白、小麦蛋白、小麦蛋白分解ペプチド、加水分解小麦蛋白、カゼイン分解ペプチド、アシル化ペプチド(パルミトイルオリゴペプチド、パルミトイルペンタペプチド、パルミトイルテトラペプチド等)等が挙げられる。 Examples of the peptide or a derivative thereof include keratin-degrading peptide, hydrolyzed keratin, collagen, fish-derived collagen, atelocollagen, gelatin, elastin, elastin-degrading peptide, collagen-degrading peptide, hydrolyzed collagen, hydroxypropylammonium chloride hydrolyzed collagen, and the like. Elastin-degrading peptide, conchiolin-degrading peptide, hydrolyzed conchiolin, silk proteolytic peptide, hydrolyzed silk, lauroyl hydrolyzed silk sodium, soybean proteolytic peptide, hydrolyzed soybean protein, wheat protein, wheat proteolytic peptide, hydrolyzed wheat protein, Examples thereof include casein-degrading peptides and acylated peptides (palmitoyl oligopeptide, palmitoyl pentapeptide, palmitoyl tetrapeptide, etc.).
上記アミノ酸又はその誘導体としては、例えば、ベタイン(トリメチルグリシン)、プロリン、ヒドロキシプロリン、アルギニン、リジン、セリン、グリシン、アラニン、フェニルアラニン、β−アラニン、スレオニン、グルタミン酸、グルタミン、アスパラギン、アスパラギン酸、システイン、シスチン、メチオニン、ロイシン、イソロイシン、バリン、ヒスチジン、タウリン、γ−アミノ酪酸、γ−アミノ−β−ヒドロキシ酪酸、カルニチン、カルノシン、クレアチン等が挙げられる。 Examples of the amino acid or a derivative thereof include betaine (trimethylglycine), proline, hydroxyproline, arginine, lysine, serine, glycine, alanine, phenylalanine, β-alanine, threonine, glutamic acid, glutamine, asparagine, aspartic acid, cysteine, and the like. Examples thereof include cystine, methionine, leucine, isoleucine, valine, histidine, taurine, γ-aminobutyric acid, γ-amino-β-hydroxybutyric acid, carnitine, carnosin and creatine.
上記洗浄成分としては、例えば、ラウリン酸カリウム、ミリスチン酸カリウム、パルミチン酸カリウム又はステアリン酸カリウム等のアルカリ金属塩、アルカノールアミド塩又はアミノ酸塩等から選ばれる石けん類;ココイルグルタミン酸Na、ココイルメチルタウリンNa等のアミノ酸系界面活性剤;ラウレス硫酸Na等のエーテル硫酸エステル塩;ラウリルエーテル酢酸Na等のエーテルカルボン酸塩;アルキルスルホコハク酸エステルNa等のスルホコハク酸エステル塩;ヤシ油脂肪酸モノエタノールアミド、ヤシ油脂肪酸ジエタノールアミド等の脂肪酸アルカノールアミド;ラウリルリン酸ナトリウム、ポリオキシエチレンラウリルエーテルリン酸ナトリウム等のモノアルキルリン酸エステル塩;ヤシ油脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン、ラウリルジメチルアミノ酢酸ベタイン、2−アルキル−N−カルボキシメチル−N−ヒドロキシエチルイミダゾリニウムベタイン、ラウリルヒドロキシスルホベタイン及びラウロイルアミドエチルヒドロキシエチルカルボキシメチルベタインヒドロキシプロピルリン酸ナトリウム等のベタイン型両性界面活性剤;ラウリルアミノプロピオン酸ナトリウム等のアミノ酸型両性界面活性剤等が挙げられる。 Examples of the cleaning component include soaps selected from alkali metal salts such as potassium laurate, potassium myristate, potassium palmitate or potassium stearate, alkanolamide salts or amino acid salts; Na cocoyl glutamate, Na cocoyl methyl taurine Amino acid-based surfactants such as; ether sulfate ester salts such as laureth sulfate Na; ether carboxylates such as lauryl ether acetate; sulfosuccinic acid ester salts such as alkyl sulfosuccinate Na; palm oil fatty acid monoethanolamide, palm oil Amino acid alkanolamides such as fatty acid diethanolamide; monoalkyl phosphate esters such as sodium lauryl phosphate and sodium polyoxyethylene lauryl ether phosphate; coconut oil fatty acid amide propyldimethylaminoacetic acid betaine, lauryldimethylaminoacetic acid betaine, 2-alkyl Betain-type amphoteric surfactants such as -N-carboxymethyl-N-hydroxyethyl imidazolinium betaine, lauryl hydroxysulfobetaine and lauroylamide ethyl hydroxyethyl carboxymethyl betaine hydroxypropyl phosphate; amino acids such as sodium lauryl aminopropionate Examples include type amphoteric surfactants.
上記角質柔軟成分としては、例えば、乳酸、サリチル酸、グルコール酸、クエン酸、リンゴ酸、フルーツ酸、フィチン酸、尿素、イオウ等が挙げられる。 Examples of the keratin softening component include lactic acid, salicylic acid, glucolic acid, citric acid, malic acid, fruit acid, phytic acid, urea, and sulfur.
上記細胞賦活化成分としては、例えば、γ−アミノ酪酸等のアミノ酸類;レチノール、チアミン、リボフラビン、塩酸ピリドキシン、パントテン酸類等のビタミン類;グリコール酸、乳酸等のα−ヒドロキシ酸類;タンニン、フラボノイド、サポニン、感光素301号等が挙げられる。 Examples of the cell activating component include amino acids such as γ-aminobutyric acid; vitamins such as retinol, thiamine, riboflavin, pyridoxine hydrochloride, and pantothenic acids; α-hydroxy acids such as glycolic acid and lactic acid; tannins and flavonoids. Examples thereof include saponin and photosensitizer No. 301.
上記血行促進作用成分としては、植物(例えば、オタネニンジン、アシタバ、アルニカ、イチョウ、ウイキョウ、エンメイソウ、オランダカシ、カミツレ、ローマカミツレ、カロット、ゲンチアナ、ゴボウ、コメ、サンザシ、シイタケ、ショウガ、セイヨウサンザシ、セイヨウネズ、センキュウ、センブリ、タイム、チョウジ、チンピ、トウガラシ、トウキ、トウニン、トウヒ、ニンジン、ニンニク、ブッチャーブルーム、ブドウ、ボタン、マロニエ、メリッサ、ユズ、ヨクイニン、リョクチャ、ローズマリー、ローズヒップ、チンピ、トウキ、トウヒ、モモ、アンズ、クルミ、トウモロコシ等)に由来する成分;アセチルコリン、イクタモール、カンタリスチンキ、ガンマーオリザノール、セファランチン、トラゾリン、ニコチン酸トコフェロール、グルコシルヘスペリジン等が挙げられる。 Examples of the blood circulation promoting action component include plants (for example, Otaneninjin, Ashitaba, Arnica, Ginkgo, Angelica acutiloba, Enmeisou, Dutch oak, Chamomile, Roman chamomile, Carrot, Gentiana, Gobo, Rice, Sanzashi, Shiitake, Grape, Seiyousanzashi, Seiyounezu. , Senkyu, Senburi, Thyme, Chouji, Chimpi, Togarashi, Touki, Tounin, Tohi, Carrot, Garlic, Butcher Bloom, Grape, Button, Maronie, Melissa, Yuzu, Yokuinin, Ryokucha, Rosemary, Rosehip, Chimpi, Touki, Ingredients derived from (Angelica acutiloba, peach, apricot, walnut, corn, etc.); acetylcholine, ictamol, cantalistinki, gamma oryzanol, cepharanthin, trazoline, tocopherol nicotinate, glucosyl hesperidine and the like.
[美容組成物の製造方法]
本発明の美容組成物の製造方法は特に制限されず、必須成分であるIPL照射様作用剤、必要に応じて配合されるその他の成分(上記任意成分、後述する基剤又は担体、添加剤等)を適宜選択、配合して、常法により製造することができる。[Manufacturing method of cosmetological composition]
The method for producing the cosmetological composition of the present invention is not particularly limited, and an IPL irradiation-like agent which is an essential component, other components to be blended as necessary (the above-mentioned optional component, a base or carrier described later, an additive, etc.) ) Can be appropriately selected and blended, and can be produced by a conventional method.
[美容組成物の用途]
本発明の美容組成物は、美容医のIPL施術(光施術)着想のアプローチで、IPL照射と同様の全顔に対する効果を期待して使用されるものである。本発明の美容組成物を用いることで、全顔の美白、スキントーンの向上効果が得られる。また、全顔のくすみ、ハリのなさ、毛穴目立ち、乾燥などのエージング症状の改善(スキントーン改善)にも効果を奏する。このように、本発明の美容組成物は、IPL照射の代替用として、またIPL照射と併用して使用することができる。このような目的で使用する本発明の美容組成物は、例えば、美容液、化粧水、乳液、クリーム、ジェルクリーム、美容マスク(フェイスマスク)、化粧下地、ファンデーション、日焼け止め、クレンジング、洗浄剤等の外用組成物として好適に使用することができ、より好ましくは、美容液、化粧水、乳液、クリーム、ジェルクリーム等のスキンケア製品として使用することができる。[Use of beauty composition]
The cosmetological composition of the present invention is an approach of a cosmetologist's idea of IPL treatment (light treatment), and is used with the expectation of an effect on the entire face similar to IPL irradiation. By using the beauty composition of the present invention, the effect of whitening the entire face and improving the skin tone can be obtained. It is also effective in improving aging symptoms (skin tone improvement) such as dullness of the entire face, lack of firmness, conspicuous pores, and dryness. As described above, the cosmetological composition of the present invention can be used as a substitute for IPL irradiation and in combination with IPL irradiation. The beauty composition of the present invention used for such a purpose includes, for example, beauty essence, lotion, milky lotion, cream, gel cream, beauty mask (face mask), makeup base, foundation, sunscreen, cleansing, cleaning agent and the like. It can be suitably used as an external composition of, and more preferably it can be used as a skin care product such as a beauty essence, a lotion, a milky lotion, a cream, and a gel cream.
また、本発明の美容組成物は、食品組成物とすることができる。この食品組成物は、健康食品、栄養補助食品(バランス栄養食、サプリメントなどを含む)として好適に用いることができる。また、保健機能食品(特定保健用食品(疾病リスク低減表示、規格基準型を含む))に好適である。 In addition, the cosmetological composition of the present invention can be a food composition. This food composition can be suitably used as a health food, a dietary supplement (including a balanced nutritional diet, a supplement, etc.). It is also suitable for foods with health claims (foods for specified health use (including disease risk reduction labeling and standard type)).
[製剤(外用組成物)]
本発明の美容組成物が外用組成物である場合は、その必須成分及び上記で説明したその他の任意成分等を、化粧品、医薬品、医薬部外品に通常使用される基剤又は担体、及び必要に応じて、後述する添加剤と共に常法に従い混合して、必要に応じて乳化又は可溶化を行い、各種の製剤形態の美容組成物とすることができる。[Formulation (external composition)]
When the cosmetological composition of the present invention is an external composition, the essential ingredients and other optional ingredients described above are used as a base or carrier usually used for cosmetics, pharmaceuticals, quasi-drugs, and necessary. Therefore, it can be mixed with an additive described later according to a conventional method and emulsified or solubilized as necessary to obtain a cosmetological composition in various formulation forms.
上記基剤又は担体としては、例えば、流動パラフィン、スクワラン、ワセリン、ゲル化炭化水素(プラスチベース等)、オゾケライト、α−オレフィンオリゴマー、軽質流動パラフィン等の炭化水素;メチルポリシロキサン、環状シリコーン、変性シリコーン、シリコーンレジン等のシリコーン油;ヤシ油、オリーブ油、コメヌカ油、シアバター等の油脂;ホホバ油、ミウロウ、キャンデリラロウ、ラノリン等のロウ類;セタノール、セトステアリルアルコール、ステアリルアルコール、ベヘニルアルコール、オクチルドデカノール、イソステアリルアルコール、フィトステロール、コレステロール等の高級アルコール;メチルセルロース、エチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロースポリビニルピロリドン、カラギーナン、ポリエチレングリコール、ミリスチン酸イソプロピル、ミリスチン酸オクチルドデシル、パルミチン酸イソプロピル、パルミチン酸セチル、イソノナン酸イソノニル、テトラ2−エチルヘキサン酸ペンタエリスリット等のエステル類;デキストリン、マルトデキストリン等の多糖類;エタノール等の低級アルコール;ジエチレングリコールモノエチルエーテル、等のグリコールエーテル;水等が挙げられる。 Examples of the base or carrier include hydrocarbons such as liquid paraffin, squalane, vaseline, gelled hydrocarbon (plastibase, etc.), ozokelite, α-olefin oligomer, light liquid paraffin; methylpolysiloxane, cyclic silicone, modified silicone. , Silicone oils such as silicone resins; oils and fats such as palm oil, olive oil, rice bran oil, shea butter; waxes such as jojoba oil, miuro, candelilla wax, lanolin; cetanol, cetostearyl alcohol, stearyl alcohol, behenyl alcohol, octyldodeca Higher alcohols such as ol, isostearyl alcohol, phytosterol, cholesterol; methyl cellulose, ethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose polyvinylpyrrolidone, carrageenan, polyethylene glycol, isopropyl myristate, octyldodecyl myristate, isopropyl palmitate, cetyl palmitate, Examples thereof include esters such as isononyl isononanoate and pentaerythritol tetra2-ethylhexanoate; polysaccharides such as dextrin and maltodextrin; lower alcohols such as ethanol; glycol ethers such as diethylene glycol monoethyl ether; and water.
以上説明した基剤又は担体は、1種単独で用いてもよいし、2種以上を併用してもよい。またそれらの使用量は当業者に公知の範囲から適宜選択される。 The base or carrier described above may be used alone or in combination of two or more. Moreover, the amount used thereof is appropriately selected from a range known to those skilled in the art.
[添加剤(外用組成物)]
本発明の美容組成物には、本発明の効果を損なわない範囲で、化粧品、医薬品、医薬部外品に添加される公知の添加剤、例えば、界面活性剤、酸化防止剤、着色剤、パール光沢付与剤、キレート剤、pH調整剤、保存剤、増粘剤、等を添加することができる。これらの添加剤は、1種単独で用いてもよいし、2種以上を併用することもできる。[Additives (external composition)]
The cosmetological composition of the present invention includes known additives to be added to cosmetics, pharmaceuticals and quasi-drugs, for example, surfactants, antioxidants, colorants and pearls, as long as the effects of the present invention are not impaired. A gloss-imparting agent, a chelating agent, a pH adjuster, a preservative, a thickener, and the like can be added. These additives may be used alone or in combination of two or more.
上記界面活性剤としては、非イオン性界面活性剤、陽イオン性界面活性剤、陰イオン性界面活性剤、両性界面活性剤等のいずれでもよく、例えば、ソルビタンモノイソステアレート、ソルビタンモノラウレート、ソルビタンモノパルミテート、ソルビタンモノステアレート、ペンタ−2−エチルヘキシル酸ジグリセロールソルビタン、テトラ−2−エチルヘキシル酸ジグリセロールソルビタン等のソルビタン脂肪酸エステル類;モノステアリン酸プロピレングリコール等のプロピレングリコール脂肪酸エステル類;ポリオキシエチレン硬化ヒマシ油40(HCO−40)、ポリオキシエチレン硬化ヒマシ油50(HCO−50)、ポリオキシエチレン硬化ヒマシ油60(HCO−60)、ポリオキシエチレン硬化ヒマシ油80等の硬化ヒマシ油誘導体;モノラウリル酸ポリオキシエチレン(20)ソルビタン(ポリソルベート20)、モノステアリン酸ポリオキシエチレン(20)ソルビタン(ポリソルベート60)、モノオレイン酸ポリオキシエチレン(20)ソルビタン(ポリソルベート80)、イソステアリン酸ポリオキシエチレン(20)ソルビタン等のポリオキシエチレンソルビタン脂肪酸エステル類;ポリオキシエチレンモノヤシ油脂肪酸グリセリル;グリセリンアルキルエーテル;アルキルグルコシド;ポリオキシエチレンセチルエーテル等のポリオキシアルキレンアルキルエーテル;ステアリルアミン、オレイルアミン等のアミン類;ポリオキシエチレン・メチルポリシロキサン共重合体、ラウリルPEG−9ポリジメチルシロキシエチルジメチコン、PEG−9ポリジメチルシロキシエチルジメチコン等のシリコーン系界面活性剤等が挙げられる。 The surfactant may be any of nonionic surfactants, cationic surfactants, anionic surfactants, amphoteric surfactants and the like, and for example, sorbitan monoisostearate and sorbitan monolaurate. , Polysorbate monopalmitate, sorbitan monostearate, sorbitan fatty acid esters such as penta-2-ethylhexylate diglycerol sorbitan, tetra-2-ethylhexylate diglycerol sorbitan; propylene glycol fatty acid esters such as propylene glycol monostearate; Hardened sardines such as polyoxyethylene cured sardine oil 40 (HCO-40), polyoxyethylene cured sardine oil 50 (HCO-50), polyoxyethylene cured sardine oil 60 (HCO-60), and polyoxyethylene cured sardine oil 80. Oil derivatives; polyoxyethylene monolaurate (20) sorbitan (polysorbate 20), polyoxyethylene monostearate (20) sorbitan (polysorbate 60), polyoxyethylene monooleate (20) sorbitan (polysorbate 80), isostearic acid Polyoxyethylene sorbitan fatty acid esters such as polyoxyethylene (20) sorbitan; polyoxyethylene monococonut oil fatty acid glyceryl; glycerin alkyl ether; alkyl glucoside; polyoxyalkylene alkyl ether such as polyoxyethylene cetyl ether; stearylamine, oleylamine Amins such as: polyoxyethylene / methylpolysiloxane copolymer, lauryl PEG-9 polydimethylsiloxyethyl dimethicone, PEG-9 polydimethylsiloxyethyl dimethicone and other silicone-based surfactants.
上記酸化防止剤としては、例えば、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、ソルビン酸、亜硫酸ナトリウム、アスコルビン酸、エリソルビン酸、L−システイン塩酸塩等が挙げられる。 Examples of the antioxidant include dibutylhydroxytoluene, butylhydroxyanisole, sorbic acid, sodium sulfite, ascorbic acid, erythorbic acid, L-cysteine hydrochloride and the like.
上記着色剤としては、例えば、無機顔料、天然色素等が挙げられる。 Examples of the colorant include inorganic pigments and natural pigments.
上記キレート剤としては、例えば、EDTA・2ナトリウム塩、ヒロドキシエタンジホスホン酸・カルシウム・2ナトリウム塩等が挙げられる。 Examples of the chelating agent include EDTA / disodium salt, hirodoxyetandiphosphonic acid / calcium / disodium salt and the like.
上記pH調整剤としては、例えば無機酸(塩酸、硫酸等)、有機酸(乳酸、乳酸ナトリウム、クエン酸、クエン酸ナトリウム、コハク酸、コハク酸ナトリウム等)、無機塩基(水酸化カリウム、水酸化ナトリウム等)、有機塩基(トリエタノールアミン、ジイソプロパノールアミン、トリイソプロパノールアミン等)等が挙げられる。 Examples of the pH adjuster include inorganic acids (hydrochloride, sulfuric acid, etc.), organic acids (lactic acid, sodium lactate, citrate, sodium citrate, succinate, sodium succinate, etc.), and inorganic bases (potassium hydroxide, hydroxide). (Sodium, etc.), organic bases (triethanolamine, diisopropanolamine, triisopropanolamine, etc.) and the like.
上記保存剤としては、例えば、安息香酸、安息香酸ナトリウム、デヒドロ酢酸、デヒドロ酢酸ナトリウム、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸メチル、フェノキシエタノール、カプリルヒドロキサム酸、ペンタンジオール、ヘキサンジオール、オクタンジオール等のアルカンジオール類等が挙げられる。 Examples of the preservative include benzoic acid, sodium benzoate, dehydroacetic acid, sodium dehydroacetate, ethyl paraoxybenzoate, propyl paraoxybenzoate, methyl paraoxybenzoate, phenoxyethanol, caprylhydroxamic acid, pentanediol, hexanediol, octane. Examples thereof include alkanediols such as diols.
上記増粘剤としては、例えば、ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー等のビニル系増粘剤、メチルセルロース、エチルセルロース、ヒドロキシエチルセルロース、ヒドロキシメチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、カルボキシメチルセルロース、カルボキシエチルセルロース等のセルロース系増粘剤、グアーガム、ペクチン、プルラン、ゼラチン、ローカストビーンガム、カラギーナン、寒天、キサンタンガム、アクリル酸メタクリル酸アルキル共重合体、ポリエチレングリコール、ベントナイト、アルギン酸、アルギン酸プロピレングリコール、マクロゴール、コンドロイチン硫酸ナトリウム、ヒアルロン酸、ヒアルロン酸ナトリウム、(アクリル酸ヒドロキシエチル/アクリロイルジメチルタウリンNa)コポリマー、(アクリロイルジメチルタウリンアンモニウム/ビニルピロリドン)コポリマー等が挙げられる。 Examples of the thickener include vinyl thickeners such as polyvinyl alcohol, polyvinylpyrrolidone, and carboxyvinyl polymers, methyl cellulose, ethyl cellulose, hydroxyethyl cellulose, hydroxymethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, carboxymethyl cellulose, and carboxyethyl cellulose. Cellulose thickeners, guar gum, pectin, pullulan, gelatin, locust bean gum, carrageenan, agar, xanthan gum, alkyl methacrylate copolymer, polyethylene glycol, bentonite, alginic acid, propylene glycol alginate, macrogol, chondroitin sulfate. Examples thereof include sodium, hyaluronic acid, sodium hyaluronate, (hydroxyethyl acrylate / acryloyldimethyltaurine Na) copolymer, (acryloyldimethyltaurinammonium / vinylpyrrolidone) copolymer and the like.
[製剤形態(外用組成物)]
本発明の美容組成物が外用組成物である場合の製剤形態は特に限定されず、例えば、液剤(化粧水、ローション、美容液等)、クリーム製剤(乳液、クリーム、ジェルクリーム、バーム等)、ジェル製剤、ゼリー製剤、シャーベット製剤、エアゾール剤、フォーム製剤、スプレー製剤、貼付剤、スティック製剤、その他軟膏剤、固形剤等が挙げられる。これらの製剤は、常法、例えば第17改正日本薬局方製剤総則に記載の方法等に従い製造することができる。また目的とする安定性、使用感等を考慮し、適宜、W/O、O/W、W/O/W、O/W/O型エマルション等の剤型が選択できる。なお、貼付剤は、例えば、不織布シート、ゲルシート等に、美容液組成物、化粧水組成物、乳液組成物等を含浸させたものであってもよい。[Formulation form (external composition)]
When the beauty composition of the present invention is an external composition, the formulation form is not particularly limited, and for example, a liquid preparation (lotion, lotion, beauty essence, etc.), a cream preparation (milky lotion, cream, gel cream, balm, etc.), Examples include gel preparations, jelly preparations, sherbet preparations, aerosol preparations, foam preparations, spray preparations, patches, stick preparations, other ointments, solid preparations and the like. These preparations can be produced according to a conventional method, for example, the method described in the 17th revised Japanese Pharmacopoeia General Rules for Preparations. Further, the dosage form such as W / O, O / W, W / O / W, O / W / O type emulsion can be appropriately selected in consideration of the desired stability, usability and the like. The patch may be, for example, a non-woven fabric sheet, a gel sheet or the like impregnated with a beauty essence composition, a lotion composition, a milky lotion composition or the like.
[製剤(食品組成物)]
本発明の美容組成物が食品組成物である場合、その必須成分及び上記で説明したその他の任意成分等を、食品に通常使用される基剤又は担体、及び必要に応じて、油脂、乳化剤、分散剤、懸濁化剤、安定剤、増粘剤、甘味料、着色剤、香料、保存料、酸化防止剤、有機酸などの食品添加剤と共に混合して、製剤化すればよい。なお、食品添加剤は、上記のもの及び後述する具体的成分に限定されるわけではなく、適宜目的や必要性に応じて選択することができる。また、これらの食品添加剤は、1種を単独で又は2種以上を組み合わせて使用できる。さらに、製剤には、その他の活性成分を添加することができる。[Formulation (food composition)]
When the beauty composition of the present invention is a food composition, the essential ingredients and other optional ingredients described above are added to a base or carrier usually used in foods, and if necessary, fats and oils, emulsifiers, etc. It may be mixed with food additives such as dispersants, suspending agents, stabilizers, thickeners, sweeteners, colorants, flavors, preservatives, antioxidants and organic acids to formulate them. The food additive is not limited to the above and the specific ingredients described later, and can be appropriately selected according to the purpose and necessity. In addition, these food additives can be used alone or in combination of two or more. In addition, other active ingredients can be added to the formulation.
上記油脂としては、落花生油、ココアバター、コメ胚芽油、シソ油、亜麻仁油などの天然植物油等やこれらの硬化油、脂肪酸(中鎖脂肪酸を含む)のグリセリド(グリセリド、ジグリセリド、トリグリセリドなど)、ミツロウ等が挙げられる。中でも、ミツロウが好ましい。 Examples of the above fats and oils include natural vegetable oils such as peanut oil, cocoa butter, rice germ oil, perilla oil, and flaxseed oil, hydrogenated oils thereof, and glycerides (glycerides, diglycerides, triglycerides, etc.) of fatty acids (including medium-chain fatty acids). Mitsurou and the like can be mentioned. Of these, beeswax is preferable.
上記乳化剤、分散剤、懸濁化剤、安定剤としては、ポリエチレングリコール、プロピレングリコール、グリセリン、ソルビトールのような多価アルコール;グリセリン脂肪酸エステル;カルボキシメチルセルロースナトリウム等が挙げられる。中でも、グリセリン、グリセリン脂肪酸エステル、カルボキシメチルセルロースナトリウムが好ましい。 Examples of the emulsifier, dispersant, suspending agent and stabilizer include polyhydric alcohols such as polyethylene glycol, propylene glycol, glycerin and sorbitol; glycerin fatty acid ester; sodium carboxymethyl cellulose and the like. Of these, glycerin, glycerin fatty acid ester, and sodium carboxymethyl cellulose are preferable.
上記増粘剤としては、ローカストビーンガム、グアガム、キサンタンガム、タマリンドガム、ペクチン、カラギーナンなどが挙げられる。中でも、キサンタンガムが好ましい。 Examples of the thickener include locust bean gum, guar gum, xanthan gum, tamarind gum, pectin, carrageenan and the like. Of these, xanthan gum is preferred.
上記甘味料としては、ショ糖、果糖、麦芽糖、エリスリトール、トレハロース、マルチトール、甘草抽出物、ステビア加工甘味料、アスパルテーム、アセスルファムカリウム、ソルビトール、キシリトールなどが挙げられる。 Examples of the sweetener include sucrose, fructose, maltose, erythritol, trehalose, maltitol, licorice extract, stevia-processed sweetener, aspartame, acesulfame potassium, sorbitol, xylitol and the like.
上記保存料としては、安息香酸又はその塩、ソルビン酸又はその塩、パラオキシ安息香酸ブチル、パラオキシ安息香酸イソブチル、パラオキシ安息香酸イソプロピル、パラオキシ安息香酸エチル、パラオキシ安息香酸メチルなどが挙げられる。 Examples of the preservative include benzoic acid or a salt thereof, sorbic acid or a salt thereof, butyl paraoxybenzoate, isobutyl paraoxybenzoate, isopropyl paraoxybenzoate, ethyl paraoxybenzoate, methyl paraoxybenzoate and the like.
上記酸化防止剤としては、アスコルビン酸、アスコルビン酸ナトリウム、アスコルビン酸ステアリン酸エステル、アスコルビン酸ステアリン酸ナトリウム、アスコルビン酸パルミチン酸エステル、亜硫酸水素塩、次亜硫酸ナトリウム、二酸化硫黄、EDTAカルシウム二ナトリウム、エリソルビン酸、エリソルビン酸ナトリウム、トコフェロールなどが挙げられる。中でも、アスコルビン酸、アスコルビン酸パルミチン酸エステル、トコフェロールが好ましい。 Examples of the above-mentioned antioxidants include ascorbic acid, sodium ascorbic acid, ascorbic acid stearic acid ester, sodium ascorbic acid stearate, ascorbic acid palmitate, hydrogen sulfite, sodium hyposulfite, sulfur dioxide, EDTA calcium disodium, and erythorbic acid. , Sodium erythorbate, tocopherol and the like. Of these, ascorbic acid, ascorbic acid palmitic acid ester, and tocopherol are preferable.
有機酸としては、クエン酸、コハク酸、酒石酸、アスパルギン酸、乳酸、リンゴ酸、マロン酸、フマル酸、マレイン酸などが挙げられる。 Examples of the organic acid include citric acid, succinic acid, tartaric acid, aspargic acid, lactic acid, malic acid, malonic acid, fumaric acid, maleic acid and the like.
[pH]
本発明の美容組成物のpHは、通常pH3.0〜8.0であり、pH3.5〜7.5であることが好ましい。なお、このpHは、例えば後述するpH調整剤の使用により調整することができる。ただし、pH測定が不能又は困難な製剤形態については、この限りではない。[PH]
The pH of the cosmetological composition of the present invention is usually pH 3.0 to 8.0, preferably pH 3.5 to 7.5. This pH can be adjusted, for example, by using a pH adjuster described later. However, this does not apply to formulations in which pH measurement is impossible or difficult.
<スクリーニング方法>
本発明は、スキントーン向上用成分のスクリーニング方法、スキントーン改善用成分のスクリーニング方法も含む。本発明のスクリーニング方法は、皮膚細胞にIPL照射することで発現が変化する遺伝子を指標にすることを特徴とした方法であり、皮膚培養細胞に被験物質を作用させる工程(1)、上記皮膚培養細胞における上記遺伝子発現を測定する工程(2)を少なくとも含む。本発明のスクリーニング方法によると、IPL照射(光施術)を受けた場合と同様の効果が得られるスキントーン向上用成分、スキントーン改善成分を効率的に得ることができる。<Screening method>
The present invention also includes a method for screening a component for improving skin tone and a method for screening a component for improving skin tone. The screening method of the present invention is a method characterized by using a gene whose expression is changed by irradiating skin cells with IPL as an index, and is a step (1) of allowing a test substance to act on cultured skin cells, the above-mentioned skin culture. At least the step (2) of measuring the gene expression in the cell is included. According to the screening method of the present invention, it is possible to efficiently obtain a skin tone improving component and a skin tone improving component that can obtain the same effect as when receiving IPL irradiation (light treatment).
工程(1):上記皮膚培養細胞としては、メラニン細胞を含む細胞集団であれば特に限定されないが、例えば表皮細胞、真皮細胞、培養皮膚モデル等を用いることができる。上記培養皮膚モデルとして、MEL−300A(MatTek社)やEFT−400(MatTek社)などの使用がより好ましい。上記皮膚培養細胞に被験物質を添加し、2時間から72時間程度培養する。陰性対照としては、被験物質を添加していないものを用意する。 Step (1): The skin culture cell is not particularly limited as long as it is a cell population containing melanocytes, but for example, epidermal cells, dermis cells, cultured skin model and the like can be used. As the cultured skin model, it is more preferable to use MEL-300A (MatTek) or EFT-400 (MatTek). The test substance is added to the skin culture cells and cultured for about 2 hours to 72 hours. As a negative control, one to which no test substance is added is prepared.
工程(2):上記工程(1)の後、細胞を回収し、常法に従ってRNAを抽出し、DNAマイクロアレイ法等にて遺伝子発現を解析する。工程(1)において被験物質を添加した群と添加しなかった群(陰性対照)のそれぞれの遺伝子発現を対応させる。この時、対応させる遺伝子としては、皮膚細胞にIPL照射することで変動が起こることが確認できているものを用いる。このような遺伝子としては、例えば、OCA2、SLC45A2、RAB27A2、HB‐EGFが挙げられる。これらの遺伝子は、IPL照射により発現が抑制又は促進されることが本発明者らにより見出された遺伝子である。本発明のスクリーニング方法においては、被験物質の添加群において、各遺伝子の発現がIPL照射の際と同様に変動するか否かを確認する。そして、IPL照射の際と同様にこれらの遺伝子の発現を変動させる被験物質を、スキントーン向上用成分、スキントーン改善用成分と判定することができる。 Step (2): After the above step (1), cells are collected, RNA is extracted according to a conventional method, and gene expression is analyzed by a DNA microarray method or the like. In step (1), the gene expression of the group to which the test substance was added and the group to which the test substance was not added (negative control) are matched. At this time, as the corresponding gene, a gene that has been confirmed to cause fluctuation by IPL irradiation of skin cells is used. Examples of such genes include OCA2, SLC45A2, RAB27A2, and HB-EGF. These genes are genes found by the present inventors that their expression is suppressed or promoted by IPL irradiation. In the screening method of the present invention, it is confirmed whether or not the expression of each gene fluctuates in the addition group of the test substance in the same manner as in the case of IPL irradiation. Then, the test substance that changes the expression of these genes as in the case of IPL irradiation can be determined to be a skin tone improving component and a skin tone improving component.
<美容方法>
本発明は、IPL照射様作用剤を使用することを特徴とする、皮膚状態を改善・向上させるための美容方法も含む。本発明の美容方法によると、IPL照射様作用剤を使用することで、IPL照射と同様の効果を得られるため、例えば、全顔の美白、スキントーンの向上効果が得られる。また、全顔のくすみ、肌理の乱れ、小じわ、毛細血管拡張症などのエージング症状の改善効果(スキントーン改善効果)が得られる。なお、上記IPL照射様作用剤の具体的な説明は、上述の美容組成物の項における説明をそのまま適用できる。<Cosmetology method>
The present invention also includes a cosmetological method for improving / improving the skin condition, which comprises using an IPL irradiation-like agent. According to the beauty method of the present invention, by using the IPL irradiation-like agent, the same effect as IPL irradiation can be obtained, so that, for example, the effect of whitening the entire face and improving the skin tone can be obtained. In addition, an effect of improving aging symptoms (skin tone improving effect) such as dullness of the entire face, disorder of texture, fine wrinkles, and telangiectasia can be obtained. As for the specific description of the IPL irradiation-like agent, the description in the section of the above-mentioned beauty composition can be applied as it is.
<IPL照射様作用剤>
本発明は、各種植物抽出物を有効成分として含有するIPL照射様作用剤も含む。上記植物抽出物としては、フラボノイドを含有する植物抽出物、海藻抽出物が好ましい。また、上記フラボノイドを含有する植物抽出物としては、アマチャヅルエキス、アーティチョークエキス、カンゾウ根エキス、ノイバラ果実エキス、セイヨウシロヤナギ樹皮エキス、メリアアザジラクタ葉エキス、マンダリンオレンジ果皮エキス、ユキノシタエキス、セイヨウオオバコ種子エキス、クダモノトケイソウ果実エキス、ホップ花エキス、タンブリッサトリコフィラ葉エキス、ローズマリーエキス、アルテアエキス及びゴボウエキスからなる群より選択される少なくとも一種の植物抽出物がより好ましい。上記海藻抽出物としては、褐藻(ガゴメコンブ、リシリコンブ、ミツイシコンブ、マコンブ、ナガコンブ、ワカメ等)、紅藻(テングサ等)、緑藻(アオノリ等)、藍藻(スピルリナ等)等が挙げられ、中でも褐藻がより好ましい。<IPL irradiation-like agent>
The present invention also includes an IPL irradiation-like agent containing various plant extracts as active ingredients. As the above-mentioned plant extract, a plant extract containing flavonoids and a seaweed extract are preferable. In addition, as plant extracts containing the above flavonoids, Amachazuru extract, Artichoke extract, Kanzo root extract, Neubara fruit extract, Shiroyanagi bark extract, Melia azalea lacta leaf extract, Mandarin orange peel extract, Yukinoshita extract, Seiyo obaco seed At least one plant extract selected from the group consisting of extracts, kudamonotokeisou fruit extracts, hop flower extracts, tambrissa trichophylla leaf extracts, rosemary extracts, artea extracts and gobo extracts is more preferred. Examples of the seaweed extract include brown algae (Gagomekonbu, Risilimb, Mitsuishikonbu, Macombu, Nagakombu, Wakame seaweed, etc.), Red algae (Gelidiaceae, etc.), Green algae (Aonori, etc.), Blue algae (Spirulina, etc.), and more. preferable.
即ち、本発明のIPL照射様作用剤としては、アマチャヅルエキス、アーティチョークエキス、カンゾウ根エキス、ノイバラ果実エキス、セイヨウシロヤナギ樹皮エキス、メリアアザジラクタ葉エキス、マンダリンオレンジ果皮エキス、ユキノシタエキス、セイヨウオオバコ種子エキス、クダモノトケイソウ果実エキス、ホップ花エキス及びタンブリッサトリコフィラ葉エキス、ローズマリーエキス、ゴボウエキス、及びアルテアエキスから成る群より選択される少なくとも一種の植物抽出物を有効成分として含むものが好ましい。また、本発明のIPL照射様作用剤としては、褐藻、紅藻、緑藻、及び藍藻から成る群より選択される少なくとも一種の海藻抽出物を有効成分として含むものが好ましく、褐藻の海藻抽出物を有効成分として含むものがより好ましい。 That is, as the IPL irradiation-like agent of the present invention, Amachazuru extract, Artichoke extract, Kanzo root extract, Neubara fruit extract, Shiroyanagi bark extract, Melia azalea lacta leaf extract, Mandarin orange peel extract, Yukinoshita extract, Seiyoobako seed It is preferable that the active ingredient contains at least one plant extract selected from the group consisting of extracts, kudamonotokeisou fruit extracts, hop flower extracts and tambrissa trichophylla leaf extracts, rosemary extracts, gobo extracts, and artea extracts. In addition, the IPL irradiation-like agent of the present invention preferably contains at least one seaweed extract selected from the group consisting of brown algae, red algae, green algae, and blue-green algae as an active ingredient, and the seaweed extract of brown algae is preferable. Those contained as an active ingredient are more preferable.
本発明のIPL照射様作用剤が有効成分として含有する植物抽出物、海藻抽出物についての詳細は、上述の美容組成物の項におけるIPL照射様作用剤についての説明を適用できる。 For details of the plant extract and seaweed extract contained in the IPL irradiation-like agent of the present invention as an active ingredient, the description of the IPL irradiation-like agent in the above-mentioned section on beauty composition can be applied.
本発明のIPL照射様作用剤によると、IPL照射と同様の効果を得られるため、これを含む美容組成物を用いると、例えば、全顔の美白、スキントーンの向上効果、全顔のくすみ、ハリのなさ、毛穴目立ち、乾燥などのエージング症状の改善効果(スキントーンの改善効果)が得られる。なお、上記IPL照射様作用剤の具体的な説明は、上述の美容組成物の項における説明をそのまま適用できる。 According to the IPL irradiation-like agent of the present invention, the same effect as IPL irradiation can be obtained. Therefore, when a beauty composition containing this is used, for example, whitening of the whole face, improvement effect of skin tone, dullness of the whole face, etc. An effect of improving aging symptoms (improving skin tone) such as lack of firmness, conspicuous pores, and dryness can be obtained. As for the specific description of the IPL irradiation-like agent, the description in the section of the above-mentioned beauty composition can be applied as it is.
以下、実施例により本発明をより詳細に説明するが、本発明はこれらにより何ら限定されない。 Hereinafter, the present invention will be described in more detail with reference to Examples, but the present invention is not limited thereto.
[試験1]IPL照射による表皮細胞内遺伝子発現の変化の解析
ヒトメラノサイトを含む表皮モデル(MatTek社;MEL−300A)を使用して以下の試験を行った。すなわちMEL−300A到着後にCO2濃度を5%に設定したインキュベータ内で、37℃で順化し、液体培地(クラボウ社:EPI−100LLMM)にて培養を開始する。順化培養終了後、トランスウェル内の表皮シートを切り出し、液体培地を含ませたガーゼに載せ実際の施術に則した条件下で照射を行った。上記方法によって調製した表皮モデルにλ560nmのフィルターを用いた光(IPL560nm)を3ミリ秒照射後、20ミリ秒おいてさらに3ミリ秒の照射を行い、6時間後及び24時間後に細胞を回収した。なお、IPL照射は、フォトフェイシャルM22(ルミナス社製)を用いて行った。それぞれの細胞から常法にしたがってRNAを抽出し、DNAマイクロアレイ法にて遺伝子発現を解析した。DNAマイクロアレイは、Human Gene 2.0ST Arrayを使用した。[Test 1] Analysis of changes in epidermal gene expression by IPL irradiation The following tests were performed using an epidermal model containing human melanocytes (MatTek; MEL-300A). That is, after arriving at MEL-300A, the cells are acclimatized at 37 ° C. in an incubator whose CO 2 concentration is set to 5%, and culture is started in a liquid medium (Kurabo Industries: EPI-100LLMM). After completion of the acclimation culture, the epidermis sheet in the transwell was cut out, placed on gauze containing a liquid medium, and irradiated under the conditions according to the actual treatment. The epidermis model prepared by the above method was irradiated with light (IPL560 nm) using a filter of λ560 nm for 3 ms, then irradiated for another 3 ms at 20 ms, and cells were collected after 6 hours and 24 hours. .. The IPL irradiation was performed using Photofacial M22 (manufactured by Luminous). RNA was extracted from each cell according to a conventional method, and gene expression was analyzed by the DNA microarray method. For the DNA microarray, Human Gene 2.0ST Array was used.
IPL560nm照射によって表皮細胞中で発現変動のあった遺伝子として、OCA2、RAB27A、SLC45A2、HB−EGFが選定された。 OCA2, RAB27A, SLC45A2, and HB-EGF were selected as genes whose expression was changed in epidermal cells by irradiation with IPL 560 nm.
[試験2]ヒトメラノサイトでのOCA2、SLC45A2、RAB27A遺伝子の発現に影響を与える物質のスクリーニング
正常ヒト成人表皮メラニン細胞(クラボウ社:NHEM)を、メラニン細胞用培地(クラボウ社:DermaLife Ma)を用いて、24ウェルプレート(CORNING)に40000cells/wellで播種し、2日間培養した。その後、各エキスサンプルを各濃度になるように培地で調製し、ポアサイズ0.2μmのフィルターに通したものを、培地を取り除いた24ウェルプレートに400μL/wellで添加し、さらに24時間培養後、細胞を回収した。常法によりRNAを抽出し、逆転写反応によりRNAからcDNAを合成し、定量リアルタイムPCRにより、OCA2、SLC45A2、RAB27Aの各遺伝子発現量を定量した。得られた値を用いてブランクに対する割合を算出した。なお、ブランクとは、各エキスサンプルを添加していない培地のみによるコントロール試験のデータをいう。結果を下記表1〜17に示す。[Test 2] Screening of substances that affect the expression of OCA2, SLC45A2, and RAB27A genes in human melanocytes Normal human adult epidermal melanin cells (Kurabo: NHEM) were used as a medium for melanocytes (Kurabo: DermaLife Ma). Then, the cells were seeded on a 24-well plate (CORNING) at 40,000 cells / well and cultured for 2 days. Then, each extract sample was prepared in a medium so as to have each concentration, passed through a filter having a pore size of 0.2 μm, added to a 24-well plate from which the medium had been removed at 400 μL / well, and further cultured for 24 hours. The cells were collected. RNA was extracted by a conventional method, cDNA was synthesized from RNA by a reverse transcription reaction, and the expression levels of each gene of OCA2, SLC45A2, and RAB27A were quantified by quantitative real-time PCR. The obtained value was used to calculate the ratio to the blank. The blank refers to the data of the control test using only the medium to which each extract sample is not added. The results are shown in Tables 1 to 17 below.
[試験3]ヒトケラチノサイトでのHB−EGF遺伝子の発現に影響を与える物質のスクリーニング
正常ヒト成人表皮細胞(クラボウ社:NHEK)を、表皮角化細胞用培地(クラボウ社:Humedia KG2)を用いて、24ウェルプレート(CORNING)に40000cells/wellで播種し、1日間培養した。その後、各エキスサンプルを各濃度になるように培地で調製し、ポアサイズ0.2μmのフィルターに通したものを、培地を取り除いた24ウェルプレートに400μL/wellで添加し、さらに24時間培養後、細胞を回収した。常法によりRNAを抽出し、逆転写反応によりRNAからcDNAを合成し、定量リアルタイムPCRにより、HB−EGFの各遺伝子発現量を定量した。得られた値を用いてブランクに対する割合を算出した。なお、ブランクとは、各エキスサンプルを添加していない培地のみによるコントロール試験のデータをいう。結果を下記表18に示す。[Test 3] Screening of substances that affect the expression of the HB-EGF gene in human keratinocytes Normal human adult epidermal cells (Kurabo: NHEK) were used in a medium for epidermal keratinocytes (Kurabo: Humania KG2). , 24-well plates (CORNING) were seeded at 40,000 cells / well and cultured for 1 day. Then, each extract sample was prepared in a medium so as to have each concentration, passed through a filter having a pore size of 0.2 μm, added to a 24-well plate from which the medium had been removed at 400 μL / well, and further cultured for 24 hours. The cells were collected. RNA was extracted by a conventional method, cDNA was synthesized from RNA by a reverse transcription reaction, and the expression level of each gene of HB-EGF was quantified by quantitative real-time PCR. The obtained value was used to calculate the ratio to the blank. The blank refers to the data of the control test using only the medium to which each extract sample is not added. The results are shown in Table 18 below.
以上から、本発明の美容組成物及び美容方法は、本来より肌色のトーンが濃い肌を明るく導く効果(スキントーンの向上効果)も期待でき、本発明の美容組成物は、スキントーン向上剤としても使用できる。また、本発明の美容組成物及び美容方法は、全顔のくすみ、ハリのなさ、毛穴目立ち、乾燥等のエージング症状の改善効果(スキントーン改善効果)も期待でき、スキントーン改善剤としても使用できる。 From the above, the beauty composition and the beauty method of the present invention can be expected to have an effect of brightening the skin having a darker skin tone (skin tone improving effect), and the beauty composition of the present invention can be used as a skin tone improving agent. Can also be used. In addition, the beauty composition and beauty method of the present invention can be expected to have an effect of improving aging symptoms (skin tone improving effect) such as dullness of the entire face, lack of firmness, conspicuous pores, and dryness, and are also used as a skin tone improving agent. it can.
以下に、本発明の美容組成物の製剤処方例を示す。 An example of prescribing the cosmetological composition of the present invention is shown below.
処方例1
(美容液)
L−アスコルビン酸 10.0(w/w%)
ハイドロキノン 0.1
ジエチレングリコールモノエチルエーテル 51.0
プロピレングリコール 23.0
アマチャヅルエキス 0.1
ノイバラ果実エキス 0.5
精製水 残量
合計 100.0%Prescription example 1
(Essence)
L-ascorbic acid 10.0 (w / w%)
Hydroquinone 0.1
Diethylene glycol monoethyl ether 51.0
Propylene glycol 23.0
Jiaogulan extract 0.1
Neubara fruit extract 0.5
Total remaining amount of purified water 100.0%
処方例2
(美容液)
3−O−エチルアスコルビン酸 3.0(w/w%)
ジエチレングリコールモノエチルエーテル 30.0
プロピレングリコール 20.0
グリセリン 4.0
アルテアエキス 1.0
アーティチョークエキス 10.0
精製水 残量
合計 100.0%Prescription example 2
(Essence)
3-O-ethylascorbic acid 3.0 (w / w%)
Diethylene glycol monoethyl ether 30.0
Propylene glycol 20.0
Glycerin 4.0
Artea Extract 1.0
Artichoke extract 10.0
Total remaining amount of purified water 100.0%
処方例3
(化粧水)
トラネキサム酸 1.5(w/w%)
サリチル酸 0.1
ヒアルロン酸ナトリウム 0.2
グリセリン 2.0
1,3−ブチレングリコール 10.0
ポリオキシプロピレンメチルグルコシド 0.2
アセチル化ヒアルロン酸ナトリウム 0.01
ヒドロキシエチルセルロース 0.05
パラオキシ安息香酸メチル 0.15
着香剤 0.03
油溶性甘草エキス 0.0001
精製水 残量
合計 100.0%Prescription example 3
(Toner)
Tranexamic acid 1.5 (w / w%)
Salicylic acid 0.1
Sodium hyaluronate 0.2
Glycerin 2.0
1,3-butylene glycol 10.0
Polyoxypropylene methyl glucoside 0.2
Acetylated sodium hyaluronate 0.01
Hydroxyethyl cellulose 0.05
Methyl paraoxybenzoate 0.15
Fragrance 0.03
Oil-soluble licorice extract 0.0001
Total remaining amount of purified water 100.0%
処方例4
(化粧水)
トラネキサム酸 1.5(w/w%)
サリチル酸 0.1
ヒアルロン酸ナトリウム 0.2
グリセリン 1.0
ジグリセリン 0.5
1,3−ブチレングリコール 5.0
ジプロピレングリコール 3.0
トレハロース 0.1
アセチル化ヒアルロン酸ナトリウム 0.01
ヒドロキシエチルセルロース 0.05
パラオキシ安息香酸メチル 0.15
着香剤 0.03
海藻エキス 0.5
ローズマリーエキス 0.3
精製水 残量
合計 100.0%Prescription example 4
(Toner)
Tranexamic acid 1.5 (w / w%)
Salicylic acid 0.1
Sodium hyaluronate 0.2
Glycerin 1.0
Diglycerin 0.5
1,3-butylene glycol 5.0
Dipropylene glycol 3.0
Trehalose 0.1
Acetylated sodium hyaluronate 0.01
Hydroxyethyl cellulose 0.05
Methyl paraoxybenzoate 0.15
Fragrance 0.03
Seaweed extract 0.5
Rosemary extract 0.3
Total remaining amount of purified water 100.0%
処方例5(化粧水)
リン酸L−アスコルビルマグネシウム 3.0(w/w%)
プラセンタエキス 0.5
トリメチルグリシン 3.0
ヒアルロン酸 0.05
ガゴメコンブ抽出物 0.3
1,3−ブチレングリコール 5.0
ポリオキシエチレン硬化ヒマシ油 1.0
パラオキシ安息香酸メチル 0.05
セイヨウシロヤナギ樹皮エキス 20.0
カンゾウ根エキス 0.01
精製水 残量
合計 100.0%Prescription example 5 (toner)
L-ascorbyl magnesium phosphate 3.0 (w / w%)
Placenta extract 0.5
Trimethylglycine 3.0
Hyaluronic acid 0.05
Gagomekonbu extract 0.3
1,3-butylene glycol 5.0
Polyoxyethylene cured castor oil 1.0
Methyl paraoxybenzoate 0.05
White willow bark extract 20.0
Licorice root extract 0.01
Total remaining amount of purified water 100.0%
処方例6(乳液)
トラネキサム酸 2.0(w/w%)
β−アルブチン 0.1
サリチル酸 0.2
ヒアルロン酸ナトリウム 0.2
ジプロピレングリコール 5.0
1,3−ブチレングリコール 8.0
グリセリン 3.0
モノステアリン酸グリセリン 1.0
カルボキシビニルポリマー 0.2
キサンタンガム 0.05
メドウフォーム油 5.0
トリ2−エチルヘキサン酸グリセリル 5.0
メチルポリシロキサン 1.0
トリエタノールアミン 0.1
トコフェロール 0.1
アセチル化ヒアルロン酸ナトリウム 0.05
エデト酸ナトリウム 0.05
パラオキシ安息香酸メチル 0.2
着香剤 0.05
ローズマリーエキス 0.1
エイジツエキス 0.1
精製水 残量
合計 100.0%Prescription example 6 (milky lotion)
Tranexamic acid 2.0 (w / w%)
β-Arbutin 0.1
Salicylic acid 0.2
Sodium hyaluronate 0.2
Dipropylene glycol 5.0
1,3-butylene glycol 8.0
Glycerin 3.0
Glycerin monostearate 1.0
Carboxyvinyl polymer 0.2
Xanthan gum 0.05
Meadowfoam oil 5.0
Glyceryl tri2-ethylhexanoate 5.0
Methylpolysiloxane 1.0
Triethanolamine 0.1
Tocopherol 0.1
Acetylated sodium hyaluronate 0.05
Sodium edetate 0.05
Methyl paraoxybenzoate 0.2
Fragrance 0.05
Rosemary extract 0.1
Agetsu extract 0.1
Total remaining amount of purified water 100.0%
処方例7(クリーム)
ニコチン酸アミド 1.0(w/w%)
グリセリン 5.0
1,3−ブチレングリコール 5.0
軽質流動パラフィン 3.0
アクリル酸メタクリル酸アルキル共重合体 0.3
アルギニン 0.3
ポリオキシエチレン硬化ヒマシ油 0.5
パラオキシ安息香酸メチル 0.2
メリアアザジラクタ葉エキス 0.5
マンダリンオレンジ果皮エキス 3.0
精製水 適量
合計 100.0%Prescription example 7 (cream)
Nicotinamide 1.0 (w / w%)
Glycerin 5.0
1,3-butylene glycol 5.0
Light liquid paraffin 3.0
Alkylate Alkylate Copolymer Acrylic Acid 0.3
Arginine 0.3
Polyoxyethylene hardened castor oil 0.5
Methyl paraoxybenzoate 0.2
Melia bruises leaf extract 0.5
Mandarin orange peel extract 3.0
Purified water Appropriate amount total 100.0%
処方例8(クリーム)
トラネキサム酸 1.0(w/w%)
アルブチン 3.0
サリチル酸 0.05
ヒアルロン酸ナトリウム 0.15
ジプロピレングリコール 8.0
ジグリセリン 5.0
グリセリン 3.0
ヒドロキシエチルウレア 3.0
イソステアリン酸ポリオキシエチレンソルビタン 0.5
モノステアリン酸グリセリン 0.4
セトステアリルグルコシド・セトステアリルアルコール 1.5
アクリル酸・メタクリル酸アルキル共重合体 0.5
メドウフォーム油 0.5
スクワラン 3.0
トリ(カプリル酸/カプリン酸)グリセリル 1.5
メチルポリシロキサン 1.0
ベヘニルアルコール 0.2
ステアリルアルコール 0.3
キサンタンガム 0.2
水酸化ナトリウム 0.1
エデト酸ナトリウム 0.1
パラオキシ安息香酸メチル 0.2
着香剤 0.1
セラミド1 0.01
セラミド2 0.01
セラミド6 0.01
ローズマリーエキス 0.001
ユキノシタエキス 0.01
タンブリッサトリコフィラ葉エキス 0.001
エイジツエキス 5.0
精製水 残量
合計 100.0%Prescription example 8 (cream)
Tranexamic acid 1.0 (w / w%)
Arbutin 3.0
Salicylic acid 0.05
Sodium hyaluronate 0.15
Dipropylene glycol 8.0
Diglycerin 5.0
Glycerin 3.0
Hydroxyethylurea 3.0
Polyoxyethylene sorbitan isostearate 0.5
Glycerin monostearate 0.4
Setostearyl glucoside / setostearyl alcohol 1.5
Acrylic acid / alkyl methacrylate copolymer 0.5
Meadowfoam oil 0.5
Squalene 3.0
Tri (caprylic acid / capric acid) glyceryl 1.5
Methylpolysiloxane 1.0
Behenyl alcohol 0.2
Stearyl alcohol 0.3
Xanthan gum 0.2
Sodium hydroxide 0.1
Sodium edetate 0.1
Methyl paraoxybenzoate 0.2
Fragrance 0.1
Ceramide 1 0.01
Ceramide 2 0.01
Ceramide 6 0.01
Rosemary extract 0.001
Yukinoshita extract 0.01
Tambrissa trichophylla leaf extract 0.001
Agetsu Extract 5.0
Total remaining amount of purified water 100.0%
処方例9(美容液)
ニコチン酸アミド 5.0(w/w%)
グリセリン 2.0
1,3−ブチレングリコール 3.0
スクワラン 2.0
トリエチルヘキサノイン 1.0
カルボキシビニルポリマー 0.2
(アクリロイルジメチルタウリンアンモニウム/ビニルピロリドン)
コポリマー 0.2
ポリオキシエチレンポリオキシプロピレンブチルエーテル
(17E.O.) (17P.O.) 0.5
ポリオキシプロピレンメチルグルコシド 0.5
トリエタノールアミン 0.15
水素添加大豆リン脂質 0.5
パラオキシ安息香酸メチル 0.2
ビルベリー葉エキス 0.05
コンフリー葉エキス 0.05
精製水 適量
合計 100.0%Prescription example 9 (essence)
Nicotinamide 5.0 (w / w%)
Glycerin 2.0
1,3-butylene glycol 3.0
Squalan 2.0
Triethylhexanoin 1.0
Carboxyvinyl polymer 0.2
(Acryloyl dimethyl taurine ammonium / vinylpyrrolidone)
Copolymer 0.2
Polyoxyethylene Polyoxypropylene Butyl Ether (17EO) (17PO) 0.5
Polyoxypropylene methyl glucoside 0.5
Triethanolamine 0.15
Hydrogenated soybean phospholipid 0.5
Methyl paraoxybenzoate 0.2
Blueberry leaf extract 0.05
Comfrey leaf extract 0.05
Purified water Appropriate amount total 100.0%
処方例10(美容液)
ニコチン酸アミド 5.0(w/w%)
ジプロピレングリコール 5.0
1,3−ブチレングリコール 5.0
軽質流動パラフィン 2.0
メチルフェニルポリシロキサン 1.0
キサンタンガム 0.5
(PEG−240/デシルテトラデセス−20/HDI)コポリマー
1.5
オレイン酸コレステリル 0.2
ポリオキシエチレン硬化ヒマシ油 0.5
水素添加大豆リン脂質 0.2
ペンタンジオール 1.0
フェノキシエタノール 0.2
マカデミアナッツ脂肪酸フィトステリル 0.1
ヒメフウロエキス 0.05
カンゾウ根エキス 0.05
精製水 適量
合計 100.0%Prescription example 10 (essence)
Nicotinamide 5.0 (w / w%)
Dipropylene glycol 5.0
1,3-butylene glycol 5.0
Light liquid paraffin 2.0
Methylphenyl polysiloxane 1.0
Xanthan gum 0.5
(PEG-240 / decyltetradeceth-20 / HDI) copolymer
1.5
Cholesteryl oleate 0.2
Polyoxyethylene hardened castor oil 0.5
Hydrogenated soybean phospholipid 0.2
Pentanediol 1.0
Phenoxyethanol 0.2
Macademia nut fatty acid phytosteryl 0.1
Himefuuro extract 0.05
Licorice root extract 0.05
Purified water Appropriate amount total 100.0%
処方例11(クリーム)
ニコチン酸アミド 5.0(w/w%)
グリセリン 5.0
1,3−ブチレングリコール 10.0
1,2−ペンタンジオール 0.5
植物性スクワラン 5.0
トリ(カプリル・カプリン酸)グリセリル 1.0
メチルポリシロキサン 1.0
カルボキシビニルポリマー 0.4
キサンタンガム 0.05
モノステアリン酸ポリオキシエチレンソルビタン 1.5
モノステアリン酸ソルビタン 0.5
ポリオキシエチレンセチルエーテル 0.2
グリセリンモノ2−エチルヘキシルエーテル 0.5
セラミド2 0.0005
セラミド6II 0.00005
海藻エキス(1) 2.0%
アルテアエキス 0.01
pH調整剤 適量
精製水 適量
合計 100.0%Prescription example 11 (cream)
Nicotinamide 5.0 (w / w%)
Glycerin 5.0
1,3-butylene glycol 10.0
1,2-Pentanediol 0.5
Vegetable squalane 5.0
Tri (capryl capric acid) glyceryl 1.0
Methylpolysiloxane 1.0
Carboxyvinyl polymer 0.4
Xanthan gum 0.05
Polyoxyethylene sorbitan monostearate 1.5
Sorbitan monostearate 0.5
Polyoxyethylene cetyl ether 0.2
Glycerin mono2-ethylhexyl ether 0.5
Ceramide 2 0.0005
Ceramide 6II 0.00005
Seaweed extract (1) 2.0%
Artea Extract 0.01
pH adjuster Appropriate amount Purified water Appropriate amount Total 100.0%
処方例12(日焼け止め)
テトラ2−ヘキシルデカン酸アスコルビル 0.1(w/w%)
トリメチルグリシン 1.0
パラメトキシケイ皮酸2−エチルヘキシル 10.0
デカメチルシクロペンタシロキサン 20.0
パルミチン酸オクチル 10.0
ポリオキシエチレン・メチルポリシロキサン共重合体 3.0
メチルハイドロジェンポリシロキサン処理
低温焼成酸化亜鉛 15.0
ポリアクリル酸アルキル 5.0
グリセリン 5.0
無水エタノール 5.0
1,3−ブチレングリコール 3.0
パンテノール 0.1
香料 0.1
セラミド2 0.001
セラミド3 0.001
セラミド6 0.001
セイヨウオオバコ種子エキス 0.01
クダモノトケイソウ果実エキス 0.1
精製水 残量
合計 100.0%Prescription example 12 (sunscreen)
Ascorbyl tetra2-hexyldecanoate 0.1 (w / w%)
Trimethylglycine 1.0
2-Ethylhexyl paramethoxycinnamate 10.0
Decamethylcyclopentasiloxane 20.0
Octyl palmitate 10.0
Polyoxyethylene / methylpolysiloxane copolymer 3.0
Methyl hydrogen polysiloxane treated low temperature calcined zinc oxide 15.0
Alkylate polyacrylate 5.0
Glycerin 5.0
Absolute ethanol 5.0
1,3-butylene glycol 3.0
Panthenol 0.1
Fragrance 0.1
Ceramide 2 0.001
Ceramide 3 0.001
Ceramide 6 0.001
Broadleaf plantain seed extract 0.01
Passionflower fruit extract 0.1
Total remaining amount of purified water 100.0%
処方例13(クレンジング)
L−アスコルビン酸2−グルコシド 0.1(w/w%)
トリイソステアリン酸PEG−20グリセリル 12.0
イソステアリン酸ポリグリセリル−10 8.0
パルミチン酸エチルヘキシル 30.0
トリエチルヘキサノイン 20.0
ミネラルオイル 25.0
ジフェニルシロキシフェニルトリメチコン 1.0
ホップ花エキス 0.0001
精製水 残量
合計 100.0%Prescription example 13 (cleansing)
L-ascorbic acid 2-glucoside 0.1 (w / w%)
PEG-20 glyceryl triisostearate 12.0
Polyglyceryl isostearate-10 8.0
Ethylhexyl palmitate 30.0
Triethylhexanoin 20.0
Mineral oil 25.0
Diphenylsiloxyphenyltrimethicone 1.0
Hop flower extract 0.0001
Total remaining amount of purified water 100.0%
処方例14(クレンジング)
L−アスコルビン酸2−グルコシド 0.1(w/w%)
トリイソステアリン酸PEG−20グリセリル 12.0
イソステアリン酸ポリグリセリル−10 8.0
パルミチン酸エチルヘキシル 28.0
トリエチルヘキサノイン 20.0
ミネラルオイル 20.0
ジフェニルシロキシフェニルトリメチコン 1.0
海藻エキス 0.0001
アルテアエキス 0.0001
精製水 残量
合計 100.0%Prescription example 14 (cleansing)
L-ascorbic acid 2-glucoside 0.1 (w / w%)
PEG-20 glyceryl triisostearate 12.0
Polyglyceryl isostearate-10 8.0
Ethylhexyl palmitate 28.0
Triethylhexanoin 20.0
Mineral oil 20.0
Diphenylsiloxyphenyltrimethicone 1.0
Seaweed extract 0.0001
Artea Extract 0.0001
Total remaining amount of purified water 100.0%
処方例15(ソフトカプセル:食品組成物)
以下の食品組成物の処方例中の数値の単位は「重量部」である。
カプセル内容物
月見草油 120
加水分解性タンニン 20
加水分解大豆タンパク 20
ハス胚芽エキス 5
セラミド 3
ヒアルロン酸 0.5
CoQ10 2
ヘマトコッカス藻色素抽出物(アスタキサンチン含有) 4
ビタミンC 1
グリセリン脂肪酸エステル 10
ミツロウ 5
カプセル皮膜
ゼラチン 92
プルラン 3
グリセリン 35
着色料 3Prescription Example 15 (Soft Capsule: Food Composition)
The unit of numerical value in the formulation examples of the following food compositions is "part by weight".
Capsule contents Evening primrose oil 120
Hydrolyzable tannins 20
Hydrolyzed soy protein 20
Lotus germ extract 5
Ceramide 3
Hyaluronic acid 0.5
CoQ10 2
Haematococcus algae pigment extract (containing astaxanthin) 4
Vitamin C 1
Glycerin fatty acid ester 10
Beeswax 5
Capsule film gelatin 92
Pullulan 3
Glycerin 35
Coloring agent 3
処方例16(美容ドリンク)単位(mg)
カンゾウエキス 180
プラセンタ抽出物 180
コラーゲンペプチド 1000
アーティチョークエキス 50
プロテオグリカン 20
アマチャヅルエキス 20
ポリソルベート80 0.1
エリスリトール 3
寒天 0.5
水あめ 0.6
果糖 2
酸味料 0.5
香料 0.1
水 86.1
1日摂取量合計(mg) 1542.9Prescription example 16 (beauty drink) unit (mg)
Licorice extract 180
Placenta extract 180
Collagen peptide 1000
Artichoke extract 50
Proteoglycan 20
Jiaogulan Extract 20
Polysorbate 80 0.1
Erythritol 3
Agar 0.5
Syrup 0.6
Fructose 2
Acidulant 0.5
Fragrance 0.1
Water 86.1
Total daily intake (mg) 1542.9
処方例17(美容ドリンク)単位(mg)
海藻エキス 180
プラセンタ抽出物 180
コラーゲンペプチド 1000
プロテオグリカン 20
ローズマリーエキス 40
ポリソルベート80 0.1
エリスリトール 3
寒天 0.5
水あめ 0.6
果糖 2
酸味料 0.5
香料 0.1
水 103.2
1日摂取量合計(mg) 1530.0Prescription example 17 (beauty drink) unit (mg)
Seaweed extract 180
Placenta extract 180
Collagen peptide 1000
Proteoglycan 20
Rosemary extract 40
Polysorbate 80 0.1
Erythritol 3
Agar 0.5
Syrup 0.6
Fructose 2
Acidulant 0.5
Fragrance 0.1
Water 103.2
Total daily intake (mg) 1530.0
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2024011621A JP2024045354A (en) | 2017-11-17 | 2024-01-30 | Cosmetic composition, screening method and cosmetic method |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017222292 | 2017-11-17 | ||
JP2017222292 | 2017-11-17 | ||
JP2018146143 | 2018-08-02 | ||
JP2018146143 | 2018-08-02 | ||
PCT/JP2018/042581 WO2019098352A1 (en) | 2017-11-17 | 2018-11-16 | Cosmetic composition, screening method, and cosmetic method |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024011621A Division JP2024045354A (en) | 2017-11-17 | 2024-01-30 | Cosmetic composition, screening method and cosmetic method |
Publications (1)
Publication Number | Publication Date |
---|---|
JPWO2019098352A1 true JPWO2019098352A1 (en) | 2021-01-14 |
Family
ID=66539781
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019554433A Pending JPWO2019098352A1 (en) | 2017-11-17 | 2018-11-16 | Cosmetological composition, screening method and cosmetological method |
JP2024011621A Pending JP2024045354A (en) | 2017-11-17 | 2024-01-30 | Cosmetic composition, screening method and cosmetic method |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024011621A Pending JP2024045354A (en) | 2017-11-17 | 2024-01-30 | Cosmetic composition, screening method and cosmetic method |
Country Status (2)
Country | Link |
---|---|
JP (2) | JPWO2019098352A1 (en) |
WO (1) | WO2019098352A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7316647B2 (en) * | 2019-07-16 | 2023-07-28 | 日本メナード化粧品株式会社 | Cathepsin V activity promoter and GATA-3 production inhibitor |
JP6763497B1 (en) * | 2020-03-25 | 2020-09-30 | 大正製薬株式会社 | Mineral metabolism disorder inhibitor |
JP2021172610A (en) * | 2020-04-24 | 2021-11-01 | 株式会社 資生堂 | Cosmetic |
CN112402269A (en) * | 2020-11-30 | 2021-02-26 | 瑞兰德宝生物医药有限公司 | Moisturizing and repairing mask and preparation method thereof |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003503705A (en) * | 1999-06-29 | 2003-01-28 | ニューヨーク・ユニバーシティ | Screening method for compounds affecting melanogenesis |
JP2006076909A (en) * | 2004-09-09 | 2006-03-23 | Ichimaru Pharcos Co Ltd | Method for producing neem extract and low irritating cosmetic composition containing the same |
JP2006290749A (en) * | 2005-04-06 | 2006-10-26 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibitor |
WO2008026507A1 (en) * | 2006-09-01 | 2008-03-06 | Sapporo Breweries Limited | Skin whitening agent |
JP2009108015A (en) * | 2007-11-01 | 2009-05-21 | Pias Arise Kk | Inhibitor of stretch-mediated melanin production |
WO2009113446A1 (en) * | 2008-03-11 | 2009-09-17 | 株式会社資生堂 | Skin whitening method and screening method for factors for skin wrinkle formation suppression and/or removal |
JP2010065009A (en) * | 2008-09-12 | 2010-03-25 | Maruzen Pharmaceut Co Ltd | Skin brightener and anti-aging agent, and skin cosmetic |
JP2011020965A (en) * | 2009-07-17 | 2011-02-03 | Maruzen Pharmaceut Co Ltd | Cosmetic kit, and method of makeup |
JP2011504498A (en) * | 2007-11-19 | 2011-02-10 | スティーフェル ラボラトリーズ インコーポレイテッド | Topical whitening cosmetic composition and method of use |
JP2011032182A (en) * | 2009-07-30 | 2011-02-17 | Kose Corp | Singlet oxygen quencher, and skin preparation for external use and cosmetic each comprising the same |
JP2012126654A (en) * | 2010-12-13 | 2012-07-05 | Kao Corp | Method for producing beomycesic acid containing extract |
JP2012520349A (en) * | 2010-07-22 | 2012-09-06 | ザ プロクター アンド ギャンブル カンパニー | A method for improving the appearance of over-pigmented spots using an extract of ftcomb |
JP2012171960A (en) * | 2011-02-18 | 2012-09-10 | Amorepacific Corp | Cosmetic composition for skin bleaching |
WO2014103475A1 (en) * | 2012-12-27 | 2014-07-03 | 株式会社林原 | Skin-exterior anti-ageing composition and production method therefor |
JP2014532672A (en) * | 2011-10-29 | 2014-12-08 | メルク パテント ゲーエムベーハー | Whitening agent used for phototherapy |
JP2016027034A (en) * | 2014-06-30 | 2016-02-18 | ロート製薬株式会社 | External composition |
CN106214576A (en) * | 2016-08-30 | 2016-12-14 | 陈燕兰 | A kind of whitening and speckle dispelling skin care item and preparation method and application |
-
2018
- 2018-11-16 WO PCT/JP2018/042581 patent/WO2019098352A1/en active Application Filing
- 2018-11-16 JP JP2019554433A patent/JPWO2019098352A1/en active Pending
-
2024
- 2024-01-30 JP JP2024011621A patent/JP2024045354A/en active Pending
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003503705A (en) * | 1999-06-29 | 2003-01-28 | ニューヨーク・ユニバーシティ | Screening method for compounds affecting melanogenesis |
JP2006076909A (en) * | 2004-09-09 | 2006-03-23 | Ichimaru Pharcos Co Ltd | Method for producing neem extract and low irritating cosmetic composition containing the same |
JP2006290749A (en) * | 2005-04-06 | 2006-10-26 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibitor |
WO2008026507A1 (en) * | 2006-09-01 | 2008-03-06 | Sapporo Breweries Limited | Skin whitening agent |
JP2009108015A (en) * | 2007-11-01 | 2009-05-21 | Pias Arise Kk | Inhibitor of stretch-mediated melanin production |
JP2011504498A (en) * | 2007-11-19 | 2011-02-10 | スティーフェル ラボラトリーズ インコーポレイテッド | Topical whitening cosmetic composition and method of use |
WO2009113446A1 (en) * | 2008-03-11 | 2009-09-17 | 株式会社資生堂 | Skin whitening method and screening method for factors for skin wrinkle formation suppression and/or removal |
JP2010065009A (en) * | 2008-09-12 | 2010-03-25 | Maruzen Pharmaceut Co Ltd | Skin brightener and anti-aging agent, and skin cosmetic |
JP2011020965A (en) * | 2009-07-17 | 2011-02-03 | Maruzen Pharmaceut Co Ltd | Cosmetic kit, and method of makeup |
JP2011032182A (en) * | 2009-07-30 | 2011-02-17 | Kose Corp | Singlet oxygen quencher, and skin preparation for external use and cosmetic each comprising the same |
JP2012520349A (en) * | 2010-07-22 | 2012-09-06 | ザ プロクター アンド ギャンブル カンパニー | A method for improving the appearance of over-pigmented spots using an extract of ftcomb |
JP2012126654A (en) * | 2010-12-13 | 2012-07-05 | Kao Corp | Method for producing beomycesic acid containing extract |
JP2012171960A (en) * | 2011-02-18 | 2012-09-10 | Amorepacific Corp | Cosmetic composition for skin bleaching |
JP2014532672A (en) * | 2011-10-29 | 2014-12-08 | メルク パテント ゲーエムベーハー | Whitening agent used for phototherapy |
WO2014103475A1 (en) * | 2012-12-27 | 2014-07-03 | 株式会社林原 | Skin-exterior anti-ageing composition and production method therefor |
JP2016027034A (en) * | 2014-06-30 | 2016-02-18 | ロート製薬株式会社 | External composition |
CN106214576A (en) * | 2016-08-30 | 2016-12-14 | 陈燕兰 | A kind of whitening and speckle dispelling skin care item and preparation method and application |
Non-Patent Citations (1)
Title |
---|
山口今日子: "ゲノム人類学の最先端 vol.9 遺伝子から見る皮膚色の進化", 医学のあゆみ, vol. 249巻8号, JPN6022054452, 24 May 2014 (2014-05-24), pages 716 - 719, ISSN: 0005076376 * |
Also Published As
Publication number | Publication date |
---|---|
WO2019098352A1 (en) | 2019-05-23 |
JP2024045354A (en) | 2024-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103717202B (en) | For strengthening the cosmetic composition of collage synthesis in Skin Cell | |
CN106794124B9 (en) | Active ingredient containing a mixture of unsaturated dicarboxylic fatty acids, composition containing said ingredient and cosmetic or dermatological use | |
JPWO2019098352A1 (en) | Cosmetological composition, screening method and cosmetological method | |
TW201438757A (en) | External dermal composition for anti-ageing and method for producing the same | |
JP2005220084A (en) | Acerola seed extract-containing composition | |
CN111032009B (en) | Skin whitening agent, external skin preparation for whitening skin, and method for whitening skin | |
JP2006089452A (en) | Bleaching and cosmetic composition | |
JP2004010526A (en) | Skin care preparation for external use | |
JP4925692B2 (en) | Skin care composition | |
JP3987793B2 (en) | Topical skin preparation | |
JP6781529B2 (en) | Skin care cosmetic composition | |
JP5960505B2 (en) | Composition for external use | |
JP5602456B2 (en) | Ascorbic acid derivative | |
JP2013184942A (en) | Antioxidant and dna damage inhibitor | |
JP5863225B2 (en) | Skin care composition | |
JP6909569B2 (en) | Skin quality improver | |
JP2007137848A (en) | Cosmetic and skin care preparation | |
JP2018070452A (en) | Preadipocyte differentiation-promoting agent | |
JP2013032331A (en) | Lipid production-inhibiting agent, sebum production-inhibiting agent, and triacylglycerol production-inhibiting agent | |
JP2005089427A (en) | Skin care preparation for external use | |
JP2010229074A (en) | Ascorbic acid derivative | |
JP2003321377A (en) | Antioxidant and skin care preparation obtained using the same | |
JP7454355B2 (en) | DKK1 production promoter and method for producing the same, cosmetic composition for promoting DKK1 production and method for producing the same, and method for promoting DKK1 production | |
JP2004352628A (en) | External preparation for skin | |
JP7210176B2 (en) | Endoplasmic reticulum stress ameliorator |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20211105 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20221227 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230221 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230425 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230606 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20230804 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230928 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20231031 |